Table of Contents

 
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 10-Q

(Mark One)

     
þ
  Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
  For the quarterly period ended April 2, 2005
     
o
  Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
  For the transition period from                                           to                                          

Commission File Number 0-21074

SUPERCONDUCTOR TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of
incorporation or organization)
  77-0158076
(IRS Employer
Identification No.)

460 Ward Drive,
Santa Barbara, California 93111-2356

(Address of principal executive offices & zip code)

(805) 690-4500
(Registrant’s telephone number including area code)


     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes þ       No o

     Indicate by check mark whether the registrant is an accelerated filer (as defined by Rule 12b-2 of the Exchange Act

Yes þ       No o

As of May 5, 2005 there were 107,711,026 shares of the Registrant’s Common Stock outstanding.

 
 

1


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

INDEX TO FORM 10-Q

Three Months Ended April 2, 2005

             
SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS     3  
 
           
WHERE YOU CAN FIND MORE INFORMATION     3  
 
           
  FINANCIAL INFORMATION        
 
           
  ITEM 1 — Financial Statements        
 
           
  Condensed Consolidated Statement of Operations     4  
 
           
  Condensed Consolidated Balance Sheet     5  
 
           
  Condensed Consolidated Statement of Cash Flows     6  
 
           
  Notes to Unaudited Interim Condensed Consolidated Financial Statements.     7  
 
           
  ITEM 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations     20  
 
           
  ITEM 3. Quantitative and Qualitative Disclosures About Market Risk     28  
 
           
  ITEM 4. Disclosure Controls and Procedures     28  
 
           
  OTHER INFORMATION        
 
           
  ITEM 1 — Legal Proceedings     28  
 
           
  ITEM 5 – Other Information     29  
 
           
  ITEM 6 – Exhibits     29  
 
           
SIGNATURE     31  
  Exhibit 10.1
  Exhibit 10.2
  Exhibit 10.4
  Exhibit 31.1
  Exhibit 31.2
  Exhibit 32.1
  Exhibit 32.2

2


Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

     This report contains forward-looking statements that involve risks and uncertainties. We have made these statements in reliance on the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements relate to future events or our future performance and include, but are not limited to, statements concerning our business strategy, future commercial revenues, market growth, capital requirements, new product introductions, expansion plans and our funding requirements. Other statements contained in our filings that are not historical facts are also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and other comparable terminology.

     Forward-looking statements are not guarantees of future performance and are subject to various risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may differ materially from those expressed in forward-looking statements. They can be affected by many factors, including, those discussed under the captions “ Management’s Discussion and Analysis of Financial Condition and Results of Operations ” in this Quarterly Report on Form 10-Q and “ Business—Additional Factors That May Affect Our Future Results ” in our 2004 Annual Report on Form 10-K. Forward-looking statements are based on information presently available to senior management, and we do not assume any duty to update our forward-looking statements.

WHERE YOU CAN FIND MORE INFORMATION

     As a public company, we are required to file annually, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any of our materials on file with the SEC at the SEC’s Public Reference Room at 450 Fifth Street, N.W., Judiciary Plaza, Washington, DC 20549, as well as at the SEC’s regional office at 5757 Wilshire Boulevard, Suite 500, Los Angeles, California 90036. Our filings are available to the public over the Internet at the SEC’s website at http:\\.www.sec.gov. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room. We also provide copies of our Forms 8-K, 10-K, 10-Q, Proxy and Annual Report at no charge to investors upon request and make electronic copies of our most recently filed reports available through our website at www.suptech.com as soon as reasonably practicable after filing such material with the SEC.

3


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited)
                 
    Three Months Ended  
    April 3, 2004     April 2, 2005  
Net revenues:
               
Commercial product revenues
  $ 3,183,000     $ 3,768,000  
Government and other contract revenues
    2,241,000       571,000  
Sub license royalties
    20,000       15,000  
 
           
 
               
Total net revenues
    5,444,000       4,354,000  
 
               
Costs and expenses:
               
Cost of commercial product revenues
    3,783,000       4,199,000  
Contract research and development
    1,512,000       683,000  
Other research and development
    1,339,000       1,161,000  
Selling, general and administrative
    4,617,000       3,782,000  
Restructuring expenses
          84,000  
 
           
 
               
Total costs and expenses
    11,251,000       9,909,000  
 
           
 
               
Loss from operations
    (5,807,000 )     (5,555,000 )
 
               
Interest income
    24,000       57,000  
Interest expense
    (127,000 )     (39,000 )
 
           
 
               
Net loss
  $ (5,910,000 )   $ (5,537,000 )
 
           
 
               
Basic and diluted loss per common share
  $ (0.09 )   $ (0.05 )
 
           
 
               
Weighted average number of common shares outstanding
    69,042,053       107,711,026  
 
           

See accompanying notes to the condensed consolidated financial statements

4


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited)
                 
    December 31,     April 2,  
    2004     2005  
    (See Note)          
ASSETS
               
Current Assets :
               
Cash and cash equivalents
  $ 12,802,000     $ 7,480,000  
Accounts receivable, net
    1,434,000       1,227,000  
Inventory, net
    9,327,000       8,919,000  
Insurance settlement receivable
    4,000,000       4,000,000  
Prepaid expenses and other current assets
    906,000       826,000  
 
           
Total Current Assets
    28,469,000       22,452,000  
 
Property and equipment, net of accumulated depreciation of $15,189,000 and $15,829,000, respectively
    10,303,000       9,678,000  
Patents, licenses and purchased technology, net of accumulated amortization of $768,000 and $ 849,000, respectively
    2,833,000       2,794,000  
Goodwill
    20,107,000       20,107,000  
Other assets
    646,000       519,000  
 
           
Total Assets
  $ 62,358,000     $ 55,550,000  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current Liabilities :
               
Line of credit
  $ 938,000     $ 662,000  
Accounts payable
    2,691,000       2,855,000  
Accrued expenses
    4,601,000       3,614,000  
Legal settlement liability
    4,050,000       4,050,000  
Current portion of capitalized lease obligations and long term debt
    43,000       30,000  
 
           
Total Current Liabilities
    12,323,000       11,211,000  
 
               
Capitalized lease obligations and long term-debt
    33,000       28,000  
Other long term liabilities
    753,000       599,000  
 
           
Total Liabilities
    13,109,000       11,838,000  
 
               
Commitments and contingencies-Notes 6, 8 and 9
               
 
               
Stockholders’ Equity:
               
Preferred stock, $.001 par value, 2,000,000 shares authorized, none issued and outstanding
           
Common stock, $.001 par value, 125,000,000 shares authorized, 107,711,026 shares issued and outstanding
    108,000       108,000  
Capital in excess of par value
    196,983,000       196,983,000  
Notes receivable from stockholder
    (820,000 )     (820,000 )
Accumulated deficit
    (147,022,000 )     (152,559,000 )
 
           
Total Stockholders’ Equity
    49,249,000       43,712,000  
 
           
 
               
Total Liabilities and Stockholders’ Equity
  $ 62,358,000     $ 55,550,000  
 
           

See accompanying notes to the condensed consolidated financial statements

Note-December 31, 2004 balances were derived from audited financial statements

5


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited)
                 
    Three Months Ended  
    April 3, 2004     April 2, 2005  
CASH FLOWS FROM OPERATING ACTIVITIES:
               
Net loss
  $ (5,910,000 )   $ (5,537,000 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
Depreciation and amortization
    869,000       741,000  
Provision for excess and obsolete inventories
    88,000       90,000  
Forgiveness of note receivable
          150,000  
Changes in assets and liabilities:
               
Accounts receivable
    6,181,000       207,000  
Inventory
    (4,663,000 )     318,000  
Prepaid expenses and other current assets
    125,000       80,000  
Patents, licenses and purchased technology
    (118,000 )     (43,000 )
Other assets
          (23,000 )
Accounts payable, accrued expenses and other long- term liabilities
    (502,000 )     (181,000 )
 
           
Net cash used in operating activities
    (3,930,000 )     (4,198,000 )
 
               
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Purchases of property and equipment
    (1,052,000 )     (33,000 )
 
           
Net cash used in investing activities
    (1,052,000 )     (33,000 )
 
               
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Proceeds from short-term borrowings
    1,188,000       662,000  
Payments on short-term borrowings
    (3,308,000 )     (938,000 )
Payments on long-term obligations
    (595,000 )     (18,000 )
Proceeds from exercise of stock options and warrants
    473,000        
Payment of common stock issuance costs
          (797,000 )
 
           
Net cash used in financing activities
    (2,242,000 )     (1,091,000 )
 
           
 
               
Net decrease in cash and cash equivalents
    (7,224,000 )     (5,322,000 )
Cash and cash equivalents at beginning of period
    11,144,000       12,802,000  
 
           
Cash and cash equivalents at end of period
  $ 3,920,000     $ 7,480,000  
 
           

See accompanying notes to the condensed consolidated financial statements.

6


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

UNAUDITED

1. General

     Superconductor Technologies Inc. (the “Company”) was incorporated in Delaware on May 11, 1987 and maintains its headquarters in Santa Barbara, California. The Company has operated in a single industry segment, the research, development, manufacture and marketing of high-performance filters to service providers and original equipment manufacturers in the mobile wireless communications industry. The Company’s research and development contracts are used as a source of funds for its commercial technology development. The Company’s principal commercial product, the SuperLink Ò , combines high-temperature superconductors with cryogenic cooling technology to produce a filter with significant advantages over conventional filters. From 1987 to 1997, the Company was engaged primarily in research and development and generated revenues primarily from government research contracts.

     The Company continues to be involved as either contractor or subcontractor on a number of contracts with the United States government. These contracts have been and continue to provide a significant source of revenues for the Company. For the three months ended April 3, 2004 and April 2, 2005, government related contracts account for 41% and 13%, respectively, of the Company’s net revenues.

     The unaudited consolidated financial information furnished herein has been prepared in accordance with generally accepted accounting principles and reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary for a fair statement of the results of operations for the periods presented.

     The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates and such differences may be material to the financial statements. This quarterly report on Form 10-Q should be read in conjunction with the Company’s Form 10-K for the year ended December 31, 2004. The results of operations for the three months ended April 2, 2005 are not necessarily indicative of results for the entire fiscal year ending December 31, 2005.

2. Summary of Significant Accounting Policies

Basis of Presentation

     In 2004, the Company incurred a net loss of $31,217,000 and negative cash flows from operations of $21,580,000. In response, the Company reduced direct and indirect labor and cut fixed costs. The Company also consolidated its operations in Sunnyvale into its Santa Barbara facility and accelerated the implementation of a new lower cost wafer deposition process. In the first quarter of 2005, the Company incurred a net loss of $5,537,000 and negative cash flows from operations of $4,198,000.

     The principal sources of the Company’s liquidity consists of existing cash balances and funds expected to be generated from future operations. The Company believes that its existing cash resources, together with its line of credit and a planned inventory reduction, will be sufficient to fund its planned operations for at least the next twelve months. The Company has more inventory than required for current sales volumes and plans to use its excess inventory as a material source of funding in 2005. The Company believes the key factors to its liquidity in 2005 will be its ability to successfully execute on its plans to increase sales levels and to convert excess inventory to cash. There is no assurance that the Company will be able to increase sales levels or to sell excess inventory. Its cash requirements will also depend on numerous other variable factors, including the rate of growth of sales, the timing and levels of products purchased, payment terms and credit limits from manufacturers, and the timing and level of accounts receivable collections.

     If actual cash flows deviate significantly from forecasted amounts, the Company may require additional financing in the next twelve months. There is no assurance that additional financing (public or private) will be available on acceptable terms

7


Table of Contents

or at all. If the Company issues additional equity securities to raise funds, the ownership percentage of its existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If the Company cannot raise any needed funds, it might be forced to make further substantial reductions in its operating expenses, which could adversely affect its ability to implement its current business plan and ultimately its viability as a company.

     The Company’s financial statements have been prepared assuming that it will continue as a going concern. The factors described above raise substantial doubt about its ability to continue as a going concern. These financial statements do not include any adjustments that might result from this uncertainty.

Principles of Consolidation

     The interim condensed consolidated financial statements include the accounts of Superconductor Technologies Inc. and its wholly owned subsidiaries . All significant intercompany transactions have been eliminated from the consolidated financial statements.

Cash and Cash Equivalents

     Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less. Cash and cash equivalents are maintained with quality financial institutions and from time to time exceed FDIC limits.

Accounts Receivable

     The Company sells predominantly to entities in the wireless communications industry and to entities of the United States government. The Company grants uncollateralized credit to its customers. The Company performs ongoing credit evaluations of its customers before granting credit. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. The Company determines the allowance based on historical write-off experience. Past due balances are reviewed for collectibility. Accounts balances are charged off against the allowance when the Company deems it is probable the receivable will not be recovered. The Company does not have any off balance sheet credit exposure related to its customers.

Revenue Recognition

     Commercial revenues are principally derived from the sale of the Company’s SuperLink®, AmpLink, and SuperPlex products and are recognized once all of the following conditions have been met: a) an authorized purchase order has been received in writing, b) customer‘s credit worthiness has been established, c) shipment of the product has occurred, d) title has transferred, and e) if stipulated by the contract, customer acceptance has occurred and all significant vendor obligations, if any, have been satisfied.

     Contract revenues are principally generated under research and development contracts. Contract revenues are recognized utilizing the percentage-of-completion method measured by the relationship of costs incurred to total estimated contract costs. If the current contract estimate were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for the total anticipated loss. Revenues from research related activities are derived primarily from contracts with agencies of the United States Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. These contracts include cost-plus, fixed price and cost sharing arrangements and are generally short-term in nature.

     All payments to the Company for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Contract audits through 2002 are closed. Based on historical experience and review of current projects in process, management believes that the audits will not have a significant effect on the financial position, results of operations or cash flows of the Company.

Warranties

     The Company offers warranties generally ranging from one to five years, depending on the product and negotiated terms of purchase agreements with its customers. Such warranties require the Company to repair or replace defective product returned to the Company during such warranty period at no cost to the customer. An estimate by the Company for warranty related costs is recorded by the Company at the time of sale based on its actual historical product return rates and expected repair costs. Such costs have been within management’s expectations.

8


Table of Contents

Guarantees

     In connection with the sales and manufacturing of its commercial products, the Company indemnifies, without limit or term, its customers and contract manufactures against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to its products or other claims arising from its products. The Company cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under its guarantee because of the uncertainty as to whether a claim might arise and how much it might total. Historically, the Company has not incurred any expenses related to these guarantees.

Research and Development Costs

     Research and development costs are expensed as incurred and include salary, facility, depreciation and material expenses. Research and development costs incurred solely in connection with research and development contracts are charged to contract research and development expense. Other research and development costs are charged to other research and development expense.

Inventories

     Inventories are stated at the lower of cost or market, with costs primarily determined using standard costs, which approximate actual costs utilizing the first-in, first-out method. Provision for potentially obsolete or slow moving inventory is made based on management’s analysis of inventory levels and sales forecasts. Costs associated with idle capacity are expensed immediately.

Property and Equipment

     Property and equipment are recorded at cost. Equipment is depreciated using the straight-line method over their estimated useful lives ranging from three to five years. Leasehold improvements and assets financed under capital leases are amortized over the shorter of their useful lives or the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance and minor improvements are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded as other income or expense.

Patents, Licenses and Purchased Technology

     Patents and licenses are recorded at cost and are amortized using the straight-line method over the shorter of their estimated useful lives or approximately seventeen years. Purchased technology acquired through the acquisition of Conductus, Inc. is recorded at its estimated fair value and is amortized using the straight-line method over seven years.

Goodwill

     Goodwill represents the excess of purchase price over fair value of net assets acquired in connection with the acquisition of Conductus in December 2002. Conductus was acquired primarily for the synergies the acquisition would bring to our existing business of developing, manufacturing and marketing products for the commercial wireless telecommunications business and for the synergies it would have on the Company’s fund raising abilities.

     Goodwill is tested for impairment annually in the fourth quarter after the annual planning process, or earlier if events occur which require an impairment analysis be performed. The Company operates in a single business segment as a single reporting unit. The first step of the impairment test, used to identify potential impairment, compares the fair value based on market capitalization of the entire Company with its book value of its net assets, including goodwill. The market capitalization of the Company is based the closing price of its common stock as traded on NASDAQ multiplied by its outstanding common shares. If the fair value of the Company exceeds the book value of its net assets, goodwill of the Company is not considered impaired. If the book value of the net assets of the Company exceeds its fair value, the second step of the goodwill impairment test shall be performed to measure the amount of impairment loss. The second step of the goodwill impairment test, used to measure the amount of impairment loss, compares the implied fair value of the goodwill with the book value of that goodwill. If the carrying amount of the reporting unit goodwill exceeds the implied fair value of that goodwill, an impairment loss shall be recognized in an amount equal to that excess. At December 31, 2004, the fair value of the Company based on its market capitalization totaled $149.7 million, which was in excess of the total book value of the Company. Therefore, the Company’s goodwill was not

9


Table of Contents

considered impaired.

Long-Lived Assets

     The realizability of long-lived assets is evaluated periodically as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in business are written off in the period identified since they will no longer generate any positive cash flows for the Company. Periodically, long lived assets that will continue to be used by the Company need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. The Company completed such an analysis as of the fourth quarter of 2004 and determined that no write down was necessary.

Restructuring Expenses

     Liability for costs associated with an exit or disposal activity are recognized when the liability is incurred.

Loss Contingencies

     In the normal course of business the Company is subject to claims and litigation, including allegations of patent infringement. Liabilities relating to these claims are recorded when it is determined that a loss is probable and the amount of the loss can be reasonably estimated. The costs of defending the Company in such matters are expensed as incurred. Insurance proceeds recoverable are recorded when deemed probable.

Income Taxes

     The Company accounts for income taxes under the provisions of Statement of Financial Accounting Standards No. 109 (“SFAS 109”), “Accounting for Income Taxes.” SFAS 109 utilizes an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. In estimating future tax consequences, SFAS 109 generally considers all expected future events other than enactments of changes in the tax laws or rates. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

Marketing Costs

     All costs related to marketing and advertising the Company’s products are expensed as incurred or at the time the advertising takes place. Advertising costs were not material in each of the quarters ended April 3, 2004 and April 2, 2005.

Net Loss Per Share

     Basic and diluted net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding in each period. Potentially dilutive shares are not included in the calculation of diluted loss per share because their effect is antidilutive.

Stock-based Compensation

     As permitted under Statement of Financial Accounting Standards No. 123 (“SFAS 123”), “Accounting for Stock-Based Compensation”, the Company has elected to follow Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” in accounting for its stock options and other stock-based employee awards. Pro forma information regarding net loss and loss per share, as calculated under the provisions of SFAS 123, are disclosed in the notes to the financial statements. The Company accounts for equity securities issued to non-employees in accordance with the provision of SFAS 123 and Emerging Issues Task Force 96-18.

     If the Company had elected to recognize compensation expense for employee awards based upon the fair value at the grant date consistent with the methodology prescribed by SFAS 123, the Company’s net loss and net loss per share would have been increased to the pro forma amounts indicated below:

10


Table of Contents

                 
       
    Three Months Ended  
    April 3, 2004     April 2, 2005  
     
Net loss:
               
As reported
  $ (5,910,000 )   $ (5,537,000 )
Stock-based employee compensation included in net loss
           
Stock-based compensation expense determined under fair value method
    (1,668,000 )     (1,724,000 )
 
           
Pro forma
  $ (7,578,000 )   $ (7,261,000 )
 
           
Basic and Diluted Loss per Share
  $ (0.09 )   $ (0.05 )
As reported
               
Stock-based compensation expense determined under fair value method
    (0.02 )     (0.02 )
 
           
Pro forma
  $ (0.11 )   $ (0.07 )
 
           

Use of Estimates

     The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The significant estimates in the preparation of the financial statements relate to the assessment of the carrying amount of accounts receivable, inventory, intangibles, goodwill, estimated provisions for warranty costs, accruals for restructuring and lease abandonment costs, income taxes and litigation. Actual results could differ from those estimates and such differences may be material to the financial statements.

Fair Value of Financial Instruments

     The carrying amount of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to the short-term nature of these instruments. The Company estimates that the carrying amount of the debt approximates fair value based on the Company’s current incremental borrowing rates for similar types of borrowing arrangements.

Comprehensive Income (Loss)

     The Company has no items of other comprehensive income (loss) in any period other than its net loss.

Segment Information

     The Company operates in a single business segment, the research, development, manufacture and marketing of high performance products used in cellular base stations to maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Net commercial product revenues are primarily derived from the sales of the Company’s SuperLink, AmpLink and SuperPlex products. . We currently sell most of our product directly to wireless network operators in the United States. Net revenues derived principally from government research and development contracts are presented separately on the statement of operations for all periods presented. Management views its government research and development contracts as a supplementary source of revenue to fund its development of high temperature superconducting products.

Certain Risks and Uncertainties

     The Company has continued to incur operating losses. The Company’s long-term prospects and execution of its business plan are dependent upon the continued and increased market acceptance for the product.

     The Company currently sells most of its products directly to wireless network operators in the United States and its product sales have historically been concentrated in a small number of customers. In 2004, ALLTEL and Verizon Wireless accounted

11


Table of Contents

for 87% of our net commercial revenues and 61% of accounts receivable. In the three months ended April 2, 2005, ALLTEL and Verizon Wireless accounted for 87% of our commercial revenues and 60% of accounts receivable. The loss of, or reduction in, sales to either of these customers could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

     The Company currently relies on one supplier for purchases of high quality substrates for growth of high-temperature superconductor films and a limited number of suppliers for other key components of its products. The loss of any of these suppliers could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

     In connection with the sales of its commercial products, the Company indemnifies, without limit or term, its customers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to its products or other claims arising from its products. The Company cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under its guarantee because of the uncertainty as to whether a claim might arise and how much it might total.

Recent Accounting Pronouncements

     In December 2004, the Financial Accounting Standards Board issued SFAS No. 123(R) (revised 2004), “Share-Based Payment” which amends SFAS Statement 123 and will be effective for public companies for interim periods or annual periods beginning after June 15, 2005. The effective date was subsequently amended to annual periods beginning after June 15, 2005. The new standard will require the Company to recognize compensation costs in our financial statements in an amount equal to the fair value of share-based payments granted to employees and directors. The Company is currently evaluating how it will adopt the standard and evaluating the effect that the adoption of SFAS 123(R) will have on it financial position and results of operations

     In November 2004, the FASB issued SFAS No. 151, “Inventory Costs”, an amendment of ARB No. 43, Chapter 4. This statement amends the guidance in ARB No. 43, Chapter 4, Inventory Pricing, to clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). Paragraph 5 of ARB No. 43, Chapter 4, previously stated that “..under some circumstances, items such as idle facility expense, excessive spoilage, double freight, and rehandling costs may be so abnormal as to require treatment as current period charges...” SFAS No. 151 requires that those items be recognized as current-period charges regardless of whether they meet the criterion of “so abnormal.” In addition, this statement requires that allocation of fixed production overheads to the cost of conversion be based on the normal capacity of the production facilities. The provisions of SFAS 151 shall be applied prospectively and are effective for inventory costs incurred during fiscal years beginning after June 15, 2005, with earlier application permitted for inventory costs incurred during fiscal years beginning after the date this Statement was issued. The adoption of SFAS No. 151 is not expected to have a material impact on our financial position and results of operations.

3. Short Term Borrowings

     The Company has a line of credit with a bank. The line of credit expires June 15, 2006 and is structured as a sale of accounts receivable. The agreement provides for the sale of up to $5 million of eligible accounts receivable, with advances to the Company totaling 80% of the receivables sold. Advances under the agreement are collateralized by all the Company’s assets. Under the terms of the agreement, the Company continues to service the sold receivables and is subject to recourse provisions.

     Advances bear interest at the prime rate (5.75% at April 2, 2005) plus 2.50% subject to a minimum monthly charge. Outstanding amounts under this borrowing facility at April 2, 2005 totaled $662,000 and are repaid upon collection of the underlying receivables sold.

     The agreement contains representations and warranties, affirmative and negative covenants and events of default customary for financings of this type. The failure to comply with these provisions, or the occurrence of any one of the events of default, would prevent any further borrowings and would generally require the repayment of any outstanding borrowings. Such representations, warranties and events of default include (a) non-payment of debt and interest hereunder, (b) non-compliance with terms of the agreement covenants, (c) insolvency or bankruptcy, (d) material adverse change, (e) merger or consolidation where the Company’s shareholders do not hold a majority of the voting rights of the surviving entity, (f) transactions outside the normal course of business, or (g) payment of dividends.

4. Retirement of the Company’s Chief Executive Officer

12


Table of Contents

     Effective March 15, 2005, the Company’s prior Chief Executive Officer and President retired. In connection with the retirement, the Company agreed to the continuation of his salary and benefits for one year and to immediately vest and extend all his outstanding stock options. In connection with the retirement, a $150,000 loan made to the Company’s Chief Executive Officer in 2001, and in accordance with its existing terms which were in effect prior to the adoption of the Sarbanes-Oxley Act of 2002, this loan was forgiven. The Company recognized expense of $565,000 in the three months ended April 2, 2005, in connection with the Chief Executive Officer’s retirement.

5. Stockholders’ Equity

Stock Options

     As of April 2, 2005, the Company had less than 90,000 shares of common stock remaining under its 2003 Equity Incentive Plan for future equity grants. Therefore, the Company has mailed proxy statements to its stockholders requesting that they authorize an increase in the total shares available for grants under the 2003 Equity Plan from 6,000,000 shares of common stock to 12,000,000 shares of common stock. The Company is also requesting a corresponding increase in the related sublimits under the plan.

     During the quarter ended April 2, 2005, the Company’s President and Chief Executive Officer, as well as another board member, retired. In connection with these retirements, the Company modified the terms of all the stock options held by these individuals to fully vest them and to extend the term until the earlier of the fifth anniversary of the retirement or the normal expiration date. Since these options had no intrinsic value at the date of modification, the modifications did not impact the Company’s Statement of Operations.

     In connection with the employment agreement of the Company’s new President and Chief Executive Officer, the Company granted a stock option for 1,200,000 shares of stock. The stock option was granted at 100% of the market value on the date of grant and vests over four years, beginning one year after the date of grant and expires ten years from the date of grant. Vesting of these options will accelerate in the event of an involuntary termination or change in control of the Company. The Company also agreed to issue another option for an additional 1,200,000 shares of common stock upon stockholder approval of an increase in the shares authorized for grants under the 2003 Equity Incentive Plan. These options will be granted at 100% of the market value on the date of the grant. In the event the stockholders do not approve the increase, the Company will grant him options under the plan as they become available due to expirations of outstanding options.

     The following is a summary of stock option transactions under the Company’s stock option plans at April 2, 2005:

                                                         
                                    Weighted             Weighted  
                                    Average     Number of     Average  
    Number of                             Exercise     Options     Exercise  
    Shares     Price Per Share     Price     Exercisable     Price  
Balance at December 31, 2004
    9,467,248     $ 0.84           $ 49.375     $ 5.521       5,001,189     $ 6.202  
Granted
    1,264,000     $ 0.67           $ 1.33     $ 1.035                  
Exercised
                                                 
Canceled
    (507,751 )   $ 1.00           $ 35.625     $ 4.399                  
 
                                                     
Balance at April 2, 2005
    10,223,498     $ 0.67           $ 49.375     $ 5.022       6,863,284     $ 6.471  
 
                                                     

     The outstanding options expire by the end of April 2015. The exercise prices for these options range from $0.67 to $49.375 per share, for an aggregate exercise price of approximately $51.3 million. At April 2, 2005, there were 89,478 shares of common stock available for granting future options.

     The fair value of these options for purposes of the pro forma amounts in Note 2 was estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions for the three months ended April 3, 2004 and April 2, 2005: dividend yields of zero percent in each quarter; expected volatilities of 65% and 94%, respectively; risk-free interest rates of 3.44% and 4.5%, respectively; and expected life of 4.0 years in each quarter..

     The Company also hired a Vice President of Worldwide Sales early in the second quarter of 2005. The Company committed to grant him an option for 1,000,000 shares of common stock upon stockholder approval of an increase in the shares authorized for grant under the 2003 Equity Plan. These options will be granted at 100% of the market value on the

13


Table of Contents

date of the grant. In the event the stockholders do not approve the increase, the Company will grant him options under the plan as they become available due to expirations of outstanding options.

Warrants

     The following is a summary of outstanding warrants at April 2, 2005:

                     
    Common Shares
    Total and     Price      
    Currently     per      
    Exercisable     Share     Expiration Date
Warrant related to issuance of Series E Preferred Stock
    1,217,966     $ 18.91     September 29, 2005**
Warrants related to issuance of common stock
    397,857       5.50     March 10, 2007
 
    1,406,581       1.19     December 17, 2007*
 
    1,162,790       2.90     June 24, 2008*
Warrants related to April 2004 Bridge Loans
    633,562       1.46     April 28, 2011* **
 
    100,000       1.85     April 28, 2011*
Warrants assumed in connection with the Conductus, Inc. acquisition
    72,756       22.383     August 7, 2005
 
    1,095,000       4.583     September 27, 2007
 
    6,000       31.25     September 1, 2007
 
                 
Total
    6,092,512              
 
                 


*   The terms of these warrants contain net exercise provisions, wherein instead of a cash exercise holders can elect to receive common stock equal to the difference between the exercise price and the average closing sale price for common shares over 10-30 days immediately preceding the exercise date.
 
**   The terms of these warrants contain antidilution adjustment provisions.

6. Legal Proceedings

Patent Litigation

     The Company was engaged in a patent dispute with ISCO International, Inc. relating to U.S. Patent No. 6,263,215 entitled “Cryoelectronically Cooled Receiver Front End for Mobile Radio Systems.” ISCO filed a complaint on July 17, 2001 in the United States District Court for the District of Delaware against us and our wholly-owned subsidiary, Conductus, Inc. The ISCO complaint alleged that our SuperFilter product and Conductus’ ClearSite® product infringe ISCO’s patent. The matter went to trial on March 17, 2003.

     On April 3, 2003, the jury returned a unanimous verdict that our SuperFilter product does not infringe the patent in question, and that ISCO’s patent is invalid and unenforceable. The jury also awarded us $3.8 million in compensatory damages based upon a finding that ISCO engaged in unfair competition and acted in bad faith by issuing press releases and contacting our customers asserting rights under this patent.

     On April 17, 2003, the Company filed a Motion for Attorneys’ Fees and Disbursements, in which it asked the court to award it it’s attorneys’ fees and other litigation expenses. On the same date, ISCO filed a motion, asking the court to overturn the verdict and grant a new trial. In August 2003, the court rejected ISCO’s request to overturn the jury’s verdict that the patent is invalid and not infringed by the SuperFilter product, and accepted the jury’s verdict that the patent is unenforceable because of inequitable conduct committed by one of the alleged inventors. ISCO subsequently filed a notice of appeal as to this portion of the court’s decision. The court overturned the jury’s verdict of unfair competition and bad faith on the part of ISCO and the related $3.8 million compensatory damage award to us, and also denied our request for reimbursement of our legal fees associated with the case. The Company filed a notice of appeal as to this portion of the court’s decision.

     On February 3, 2005, the Appellate Court reaffirmed the unanimous jury verdict that ISCO’s US patent is invalid and unenforceable. The Appellate Court also denied the Company’s request to reinstate the jury’s $3.8 million damage award to us for unfair competition and bad faith on the part of ISCO. The trial judge had overruled the jury’s finding on this point, and the Company appealed that portion of the judge’s ruling.

14


Table of Contents

     Litigation expenses on the ISCO matter totaled $227,000 and $45,000 for the three month periods ended April 3, 2004 and April 2, 2005, respectively. The Company does not expect any further legal action related to this matter.

Class Action Lawsuits

     The Company and certain of it’s officers were named as a defendant in several substantially identical class action lawsuits filed in the United States District Court for the Central District of California in April 2004. The cases were consolidated in August 2004, and the plaintiffs filed an amended consolidated complaint in October 2004. The plaintiffs allege securities law violations by us and certain of our officers and directors under Rule 10b-5 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended. The complaint was filed on behalf of a purported class of people who purchased our stock during the period between January 9, 2004 and March 1, 2004 and seeks unspecified damages. The plaintiffs base their allegations primarily on the fact that the Company did not achieve its forecasted revenue guidance of $10 to $13 million for the first quarter of 2004.

     In February 2005 the Company settled with the lead plaintiffs appointed by the District Court to handle this matter. Under the terms of the settlement, the Company’s insurers will pay $4.0 million into a settlement fund, and the Company will pay up to $50,000 of the costs of providing notice of the settlement to settlement class members. The settlement remains subject to approval by the District Court. The Company recorded a liability in its December 31, 2004 consolidated financial statements for the proposed amount of the settlement of $4,050,000. Because the insurance carrier involved in this suit agreed to pay $4.0 million of the settlement amount, and therefore recovery from the insurance carrier was probable, a receivable was also recorded for that amount. These amounts were paid into the settlement fund in April 2005.

     Litigation expenses on this matter totaled $216,000 for the three months ended April 2, 2005. No expenses were incurred in the corresponding period of the prior year.

7. Earnings Per Share

     The computation of per share amounts for the three month periods ended April 3, 2004 and April 2, 2005 is based on the average number of common shares outstanding for the period. Options and warrants to purchase 15,252,999 and 16,316,010 shares of common stock during the three months periods ended April 3, 2004 and April 2, 2005, respectively, were not considered in the computation of diluted earnings per share because their inclusion would be anti-dilutive.

8. Commitments and Contingencies

Operating Leases

     The Company leases its offices and production facilities under non-cancelable operating leases that expire at various times over the next seven years. Generally, these leases contain escalation clauses for increases in annual renewal options and require the Company to pay utilities, insurance, taxes and other operating expenses.

     For the three months ended April 3, 2004, and April 2, 2005, rent expense was $311,000 and $296,000, respectively.

Capital Leases

     The Company leases certain property and equipment under capital lease arrangements that expire at various dates through 2007. The leases bear interest at various rates ranging from 8.56% to 14.95%.

Patents and Licenses

     The Company has entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Certain of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. In the event that the Company fails to pay minimum annual royalties, these licenses may automatically become non-exclusive or be terminated. These royalty obligations terminate in 2009 to 2020. For the three months ended April 3, 2004 and April 2, 2005, royalty expense totaled $159,000 and $48,000, respectively. Under the terms of certain royalty agreements, royalty payments made may be subject to audit. There have been no audits to date and the Company does not expect any possible future audit adjustments to be significant.

     The minimum lease payments under operating and capital leases and license obligations are as follows:

15


Table of Contents

                         
            Operating        
Year ending December 31,   Licenses     Leases     Capital Leases  
Remainder of 2005
  $ 150,000     $ 1,798,000     $ 33,000  
2006
    150,000       1,406,000       22,000  
2007
    150,000       1,234,000       15,000  
2008
    150,000       1,271,000        
 
                       
2009
    150,000       1,315,000        
 
                       
Thereafter
    1,500,000       2,653,000        
 
                 
 
                       
Total payments
  $ 2,250,000     $ 9,677,000       70,000  
 
                   
 
                       
Less: amount representing interest
                    (12,000 )
 
                     
 
                       
Present value of minimum lease
                    58,000  
 
                       
Less current portion
                    (30,000 )
 
                     
 
                       
Long term portion
                  $ 28,000  
 
                     

     In connection with the acquisition of Conductus, Inc. as of December 31, 2002 operating leases with remaining commitments totaling $2,044,000 and $1,758,000 have been abandoned or are considered unfavorable, respectively. A liability totaling $1,995,000 representing the present value of the minimum lease payments and executory costs was recorded at December 18, 2002 relating to the abandoned leases. A liability totaling $1,140,000 representing the present value of the difference between the fair market rental and lease commitment was recorded at December 31, 2002 relating to unfavorable leases. In 2004, the Company completed closure of its Sunnyvale facility. A liability totaling $279,000 was recognized representing the present value of the remainder of the lease commitment was recorded. In connection with the closure of this facility, the remaining unfavorable lease commitment of $558,000 recorded in connection with the acquisition of Conductus, Inc. was transferred to lease abandonment costs. As of April 2, 2005, the remaining minimum lease commitments on these operating leases totaled $1,071,000 and are included in the above commitment table. At April 2, 2005, the present value of the remaining liability related to the abandoned leases totaled $1,041,000. These amounts are included in accrued liabilities.

9 — Contractual Guarantees and Indemnities

Warranties

     The Company establishes reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with its customers. The Company’s warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods.

     During its normal course of business, the Company makes certain contractual guarantees and indemnities pursuant to which the Company may be required to make future payments under specific circumstances. The Company has not recorded any liability for these contractual guarantees and indemnities in the accompanying consolidated financial statements.

     A description of significant contractual guarantees and indemnities existing as of April 2, 2005 is included below.

Intellectual Property Indemnities

     The Company indemnifies certain customers and its contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to the Company’s products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, the Company is unable to determine the maximum amount of losses that it could incur related to such indemnifications.

Director and Officer Indemnities and Contractual Guarantees

16


Table of Contents

     The Company has entered into indemnification agreements with its directors and executive officers which require the Company to indemnify such individuals to the fullest extent permitted by Delaware law. The Company’s indemnification obligations under such agreements are not limited in amount or duration. Certain costs incurred in connection with such indemnifications may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed against a director or executive officer, the Company is unable to determine the maximum amount of losses that it could incur relating to such indemnifications. Historically, any amounts payable pursuant to such director and officer indemnifications have not had a material negative effect on the Company’s business, financial condition or results of operations.

     The Company has also entered into severance and change in control agreements with certain of its executives. These agreements provide for the payment of specific compensation benefits to such executives upon the termination of their employment with the Company.

General Contractual Indemnities/Products Liability

     In connection with the sales of its commercial products, the Company indemnifies, without limit or term, its customers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to its products or other claims arising from its products. The Company cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under its guarantee because of the uncertainty as to whether a claim might arise and how much it might total.

Short Term Borrowings

     Advances under the agreement are collateralized by all the Company’s assets. Under the terms of the agreement, the Company continues to service the sold receivables and is subject to recourse provisions. Under the terms of the agreement, if the bank determines that there is a material adverse change in the Company’s business, they can exercise all their rights and remedies under the agreement.

10. Restructuring Expenses

     During 2004, the Company implemented several restructuring programs to streamline its operations and reduce its cost structure. During the three months ended April 2, 2005, the Company implemented another restructuring program and reduced its workforce by another 26 positions.

     A summary of the restructuring charges for the quarter ended April 2, 2005 is as follows:

         
    Quarter Ended  
    April 2, 2005  
Severance costs
  $ 118,000  
 
       
Facility consolidation costs
    5,000  
 
       
Employee relocation cost
    10,000  
 
     
 
       
Total
  $ 133,000  
 
       
Severance costs included in cost of goods sold
    (49,000 )
 
     
 
       
Restructuring expenses
  $ 84,000  
 
     

11. Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities

17


Table of Contents

      Balance Sheet Data :

                 
    December 31,     April 2,  
    2004     2005  
Accounts receivable:
               
Accounts receivable-trade
  $ 1,043,000     $ 1,005,000  
U.S. government accounts receivable-billed
    468,000       297,000  
Less: allowance for doubtful accounts
    (77,000 )     (75,000 )
 
           
 
  $ 1,434,000     $ 1,227,000  
 
           
                 
    December 31,     April 2,  
    2004     2005  
Inventories:
               
Raw materials
  $ 3,954,000     $ 3,934,000  
Work-in-process
    3,441,000       3,688,000  
Finished goods
    7,334,000       6,703,000  
Less inventory reserve
    (5,402,000 )     (5,406,000 )
 
           
 
  $ 9,327,000     $ 8,919,000  
 
           
                 
    December 31,     April 2,  
    2004     2005  
Property and Equipment:
               
Equipment
  $ 18,240,000     $ 18,242,000  
Leasehold improvements
    6,801,000       6,814,000  
Furniture and fixtures
    451,000       451,000  
 
           
 
    25,492,000       25,507,000  
Less: accumulated depreciation and amortization
    (15,189,000 )     (15,829,000 )
 
           
 
  $ 10,303,000     $ 9,678,000  
 
           

     At December 31, 2004 and April 2, 2005, equipment includes $237,000 of assets financed under capital lease arrangements, net of $163,000 and $181,000 of accumulated amortization, respectively. Depreciation expense amounted to $662,000 and $655,000 for the three month periods ended April 3, 2004 and April 2, 2005, respectively. Depreciation expense is expected to total $2.0 million for the remainder of 2005, $2.3 million, $2.0 million, $1.4 million and $1.0 million in each of the years 2006, 2007, 2008, and 2009, respectively.

                 
    December 31,     April 2,  
    2004     2005  
Patents and Licenses:
               
Patents pending
  $ 433,000     $ 463,000  
 
               
Patents issued
    899,000       911,000  
Less accumulated amortization
    (203,000 )     (217,000 )
 
           
Net patents issued
    696,000       694,000  
 
               
Licenses
    563,000       563,000  
Less accumulated amortization
    (33,000 )     (41,000 )
 
           
Net licenses
    530,000       522,000  
 
               
Purchased technology
    1,706,000       1,706,000  
Less accumulated amortization
    (532,000 )     (591,000 )
 
           
Net purchased technology
    1,174,000       1,115,000  
 
               
 
           
 
  $ 2,833,000     $ 2,794,000  
 
           

     Amortization expense related to these items totaled $189,000 and $82,000 for the three month periods ended April 3, 2004 and April 2, 2005, respectively. Amortization expenses are expected to total $252,000 for the remainder of 2005, $344,000 in 2006 and $350,000 in each of the years 2007, 2008 and 2009.

18


Table of Contents

                 
    December 31,     April 2,  
    2004     2005  
Accrued Expenses and Other Long Term Liabilities:
               
Compensation related
  $ 1,285,000     $ 1,307,000  
Warranty reserve
    419,000       506,000  
Lease abandonment costs
    1,336,000       1,041,000  
Product line exit costs
    885,000       764,000  
Severance costs
    36,000       32,000  
Other
    1,393,000       563,000  
 
           
 
    5,354,000       4,213,000  
Less current portion
    (4,601,000 )     (3,614,000 )
 
           
Long term portion
  $ 753,000     $ 599,000  
 
           
                 
    For the three months ended,  
    April 3,     April 2,  
    2004     2005  
Warranty Reserve Activity:
               
Beginning balance
  $ 494,000     $ 419,000  
Additions
    36,000       30,000  
Deductions
          (84,000 )
Change in estimate relating to previous warranty accruals
          141,000  
 
           
Ending balance
  $ 530,000     $ 506,000  
 
           
 
               
Unfavorable Lease Costs:
               
Beginning balance
  $ 823,000     $  
Additions
           
Deductions
    (85,000 )      
Transfer to lease abandonment costs
           
 
           
Ending balance
  $ 738,000     $  
 
           
 
               
Lease Abandonment Costs:
               
Beginning balance
  $ 1,329,000     $ 1,336,000  
Additions
           
Transfers from unfavorable lease costs
           
Deductions
    (192,000 )     (295,000 )
 
           
Ending balance
  $ 1,137,000     $ 1,041,000  
 
           
 
               
Product Line Exit Costs:
               
Beginning balance
  $ 913,000     $ 885,000  
Additions
           
Deductions
    (36,000 )     (121,000 )
 
           
Ending balance
  $ 877,000     $ 764,000  
 
           
 
               
Severance Costs:
               
Beginning balance
  $ 285,000     $ 36,000  
Additions
          118,000  
Deductions
    (266,000 )     (122,000 )
 
           
Ending balance
  $ 19,000     $ 32,000  
 
           

19


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

General

          We develop, manufacture and market high performance products used with cellular base stations to maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Our solutions leverage our expertise in high-temperature superconducting (HTS) filters to “hear” wireless devices with the best possible clarity while rejecting interfering signals. We believe that this combination of interference rejection and receiver sensitivity is only possible using HTS technology. We sell our products directly to wireless carriers in the Americas, and we have plans to expand internationally. Our customers to date include ALLTEL, AT&T Wireless (now part of Cingular), Sprint, U.S. Cellular, and Verizon Wireless.

          We derive our commercial revenues from three product lines:

          • SuperLink . In order to receive uplink signals from wireless handsets, base stations require a wireless filter system to eliminate, or filter out, out-of-band interference. To address this need, we offer the SuperLink product line for the receiver front-end of base stations. These products combine specialized filters using HTS technology with a proprietary cryogenic cooler and a cooled low-noise amplifier. The result is a highly compact and reliable receiver front-end that can simultaneously deliver both high selectivity (interference rejection) and high sensitivity (detection of low level signals). SuperLink products thereby offer significant advantages over conventional filter systems.

          • AmpLink . The recently introduced AmpLink is our lower-cost receiver front-end product designed specifically to address the sensitivity requirements of wireless base stations. The AmpLink is a ground-mounted unit which includes a high-performance amplifier and up to six dual duplexers. The enhanced uplink provided by AmpLink 1900 improves PCS network coverage immediately and avoids the installation and maintenance costs associated with tower mounted amplifiers. As network interference increases, the AmpLink 1900 is easily upgradeable to include a SuperLink front-end, which uses HTS technology to maintain the same sensitivity improvement while eliminating the effects of increasing interference.

          • SuperPlex . SuperPlex, our antenna sharing solution, is a line of multiplexers that provides extremely low insertion loss and excellent cross-band isolation. Products in our SuperPlex line of high-performance multiplexers are designed to eliminate the need for additional base station antennas and reduce infrastructure costs. Relative to competing technologies, these products offer increased transmit power delivered to the base station antenna, higher sensitivity to subscriber handset signals, fast and cost-effective network overlays. The SuperPlex product family offers network performance benefits synergistic with SuperLink.

          We began commercial production of the SuperFilter (the precursor to the SuperLink) in 1997. Our initial commercial sales of our SuperLink products were to small rural providers who had the most immediate need for range extension and coverage enhancement. We sold our first systems in the fourth quarter of 1997. In 2004, Verizon Wireless and ALLTEL accounted for 87% of our net commercial revenues. In the three months ended April 2, 2005, Verizon Wireless and ALLTEL accounted for 87% of our commercial revenues.

          In our business model, we use government contracts as a source of funds for our commercial technology development. We primarily pursue government research and development contracts which compliment our commercial product development. In other words, we undertake government contract work which has the potential to add to or improve our commercial product line. These contracts often yield valuable intellectual property relevant to our commercial business. We typically own the intellectual property developed under these contracts, and the Federal Government receives a royalty-free, non-exclusive and nontransferable license to use the intellectual property for the United States.

Critical Accounting Policies and Estimates

          Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to bad debts, inventories, recovery of goodwill and long-lived assets, including intangible assets, income taxes, warranty obligations, and contingencies. We base our estimates on historical experience and on various other assumptions that we believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

20


Table of Contents

          We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of the financial statements. We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We write down our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.

          Our inventory is valued at the lower of its actual cost or the current estimated market value of the inventory. We review inventory quantities on hand and on order and record a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. Such provisions are established based on historical usage, adjusted for known changes in demands for such products, or the estimated forecast of product demand and production requirements. Our business is characterized by rapid technological change, frequent new product development and rapid product obsolescence that could result in an increase in the amount of obsolete inventory quantities on hand. As demonstrated in the past three years, demand for our products can fluctuate significantly. Our estimates of future product demand may prove to be inaccurate and we may understate or overstate the provision required for excess and obsolete inventory.

          Our net sales consist of revenue from sales of products net of trade discounts and allowances. We recognize revenue when evidence of an arrangement exists, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. At the time revenue is recognized, we provide for the estimated cost of product warranties if allowed for under contractual arrangements. Our warranty obligation is effected by product failure rates and service delivery costs incurred in correcting a product failure. Should such failure rates or costs differ from these estimates, accrued warranty costs would be adjusted.

          In connection with the sales of its commercial products, the Company indemnifies, without limit or term, its customers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to its products or other claims arising from its products. The Company cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under its guarantee because of the uncertainty as to whether a claim might arise and how much it might total.

          Contract revenues are principally generated under research and development contracts. Contract revenues are recognized utilizing the percentage-of-completion method measured by the relationship of costs incurred to total estimated contract costs. If the current contract estimate were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for the total anticipated loss. Revenues from research related activities are derived primarily from contracts with agencies of the United States Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. These contracts include cost-plus, fixed price and cost sharing arrangements and are generally short-term in nature.

          All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Based on historical experience and review of current projects in process, we believe that the audits will not have a significant effect on our financial position, results of operations or cash flows. The Defense Contract Audit Agency has audited us through 2002.

          In connection with the acquisition of Conductus we recognized $20 million of goodwill. Goodwill is tested for impairment annually in the fourth quarter after the annual planning process, or earlier if events occur which require an impairment analysis be performed. We operate in a single business segment as a single reporting unit. The first step of the impairment test, used to identify potential impairment, compares the fair value based on market capitalization of the entire Company with the book value of its net assets, including goodwill. The Company’s market capitalization is based the closing price of our common stock as traded on NASDAQ multiplied by our outstanding common shares. If the fair value of the Company exceeds the book value of our net assets, our goodwill is not considered impaired. If the book value of our net assets exceeds our fair value, the second step of the goodwill impairment test shall be performed to measure the amount of impairment loss. The second step of the goodwill impairment test, used to measure the amount of impairment loss, compares the implied fair value of the goodwill with the book value of that goodwill. If the carrying amount of the reporting unit goodwill exceeds the implied fair value of that goodwill, an impairment loss shall be recognized in an amount equal to that excess. At December 31, 2004, we tested the goodwill for possible impairment and determined that there was no impairment. The fair value of the Company based on its market capitalization totaled $149.7 million which was in excess of the total book value of the Company. Therefore, our goodwill was not considered impaired. This goodwill will again be tested for impairment in the fourth quarter of 2005 or earlier if events occur which require an earlier assessment. If the carrying amount exceeds its implied fair value, an impairment loss will be recognized equal to the excess. At April 2, 2005, the fair value of the Company based on its market capitalization had declined to $73.2 million, which is in excess of the total book value of the Company. If the market capitalization of the Company declines below the Company’s book value of its net assets before the next annual goodwill impairment test, and it is determined that the decline is other than temporary, then an impairment loss relating to the goodwill will be recognized for the amount of its carrying amount in excess of its implied fair value. Any future impairment of our

21


Table of Contents

goodwill could have a material adverse effect on our financial position and results of operations.

          We periodically evaluate the realizability of long-lived assets as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in business are written off in the period identified since they will no longer generate any positive cash flows for the Company. Periodically, long-lived assets that will continue to be used by the Company need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. We completed such an analysis as of the fourth quarter of 2004 and determined that no write down was necessary. Our estimates of future cash flows may prove to be inaccurate, and we may understate or overstate the write down of long lived assets. During the first quarter of 2005, the market capitalization of the Company declined. If the market capitalization of the Company declines below the Company’s book value, and it is deemed other than temporary, then an impairment loss relating to the Company’s long lived assets might be recognized. Any future impairment of our long-lived assets could have a material adverse effect on our financial position and results of operations.

          As permitted under Statement of Financial Accounting Standards No. 123 (SFAS 123), “Accounting for Stock-Based Compensation”, we have elected to follow Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” in accounting for its stock options and other stock-based employee awards. Pro forma information regarding net loss and loss per share, as calculated under the provisions of SFAS 123, are disclosed in the notes to the financial statements. We account for equity securities issued to non-employees in accordance with the provision of SFAS 123 and Emerging Issues Task Force 96-18.

          If we had elected to recognize compensation expense for employee awards based upon the fair value at the grant date consistent with the methodology prescribed by SFAS 123, our net loss and net loss per share would have been increased to the pro forma amounts indicated below:

                 
    Three Months Ended  
    April 3, 2004     April 2, 2005  
Net loss:
               
As reported
  $ (5,910,000 )   $ (5,537,000 )
Stock-based employee compensation included in net loss
           
Stock-based compensation expense determined under
               
fair value method
    (1,668,000 )     (1,724,000 )
 
           
Pro forma
  $ (7,578,,000 )   $ (7,261,000 )
 
           
Basic and Diluted Loss per Share
               
As reported
  $ (0.09 )   $ (0.05 )
Stock-based compensation expense determined under fair value method
    (0.02 )     (0.02 )
 
           
Pro forma
  $ (0.11 )   $ (0.07 )
 
           

          Our valuation allowance against the deferred tax assets is based on our assessments of historical losses and projected operating results in future periods. If and when we generate future taxable income in the U.S. against which these tax assets may be applied, some portion or all of the valuation allowance would be reversed and an increase in net income would consequently be reported in future years.

          We are currently involved as a defendant in a securities class action lawsuit. This matter is discussed below in “ Legal Proceedings .” In February 2005 we settled with the lead plaintiffs appointed by the District Court to handle this matter. Under the terms of the settlement, the Company’s insurers will pay $4.0 million into a settlement fund, and the Company will pay up to $50,000 of the costs of providing notice of the settlement to settlement class members. The settlement remains subject to approval by the District Court. We recorded a liability in its December 31, 2004 consolidated financial statements for the proposed amount of the settlement of $4,050,000. Because the insurance carrier involved in this suit agreed to pay $4.0 million of the settlement amount, and therefore recovery from the insurance carrier was probable, a receivable was also recorded for that amount. These amounts were paid into the settlement fund in April 2005. We periodically reassess our potential liability as additional information becomes available. If we later determine that the probable loss is greater than our reserve or expected insurance proceeds, we would record an additional reserve for the potential additional loss. The ultimate amount of further losses, if any, could materially impact our results of operations, financial condition or cash flows.

Backlog

          Our commercial backlog consists of accepted product purchase orders with scheduled delivery dates during the next twelve months. We had commercial backlog of $5.1 million at April 2, 2005, as compared to $730,000 at December 31, 2004.

22


Table of Contents

We also had at April 2, 2005 remaining minimum purchase commitments totaling $5.3 million from one customer under a general purchase agreement. We expect to fulfill these commitments during 2005, but we did not include them in our backlog because the customer has not identified the product mix and/or scheduled delivery dates.

Results of Operations

Quarter Ended April 2, 2005 as compared to the Quarter Ended April 3, 2004

     Net revenues decreased by $1.0 million, or 20%, from $5.4 million in the first quarter of 2004 to $4.4 million in the first quarter of 2005. Net revenues consist primarily of commercial product revenues and government contract revenues. We also generate some additional revenues from sublicensing our technology.

     Net commercial product revenues increased to $3.8 million in the first quarter of 2005 from $3.2 million in the first quarter of 2004, an increase of $585,000, or 18%. The increase is primarily the result of a higher sales of our SuperPlex multiplexers and AmpLink products, partially offset by decreased sales of our SuperLink product due to lower average selling prices. Our two largest customers accounted for 87% of our net commercial revenues in the first quarter of 2005, which is comparable to the first quarter in 2004. These customers generally purchase products through non-binding commitments with minimal lead-times. Consequently, our commercial product revenues can fluctuate dramatically from quarter to quarter based on changes in our customers’ capital spending patterns.

     Government contract revenues decreased to $571,000 in the first quarter of 2005 from $2.2 million in the first quarter of 2004, a decrease of $1.7 million, or 75%. This decrease is primarily attributable to the completion of contracts in 2004 that have not been replaced.

     Cost of commercial product revenues includes all direct costs, manufacturing overhead, provision for excess and obsolete inventories and restructuring and impairment charges relating to the manufacturing operations. The cost of commercial product revenue totaled $4.2 million for the first quarter of 2005 compared to $3.8 million for the first quarter of 2004, an increase of $416,000, or 11%. Increased costs result primarily from increased units shipments and changes in overhead absorption. Our cost of sales includes both variable and fixed cost components. The variable component consists primarily of materials, assembly and test labor, overhead, which includes equipment and facility depreciation, transportation costs and warranty costs. The fixed component includes test equipment and facility depreciation, purchasing and procurement expenses and quality assurance costs. Given the fixed nature of such costs, the absorption of our production overhead costs into inventory decreases and the amount of production overhead variances expensed to cost of sales increases as production volumes decline since we have fewer units to absorb our overhead costs against. Conversely, the absorption of our production overhead costs into inventory increases and the amount of production overhead variances expensed to cost of sales decreases as production volumes increase since we have more units to absorb our overhead costs against. As a result, our gross profit margins generally decrease as revenue and production volumes decline due to lower sales volume and higher amounts of production overhead variances expensed to cost of sales; and our gross profit margins generally increase as our revenue and production volumes increase due to higher sales volume and lower amounts of production overhead variances expensed to cost of sales.

     The following is an analysis of our commercial product gross profit and margins:

                                 
    For the quarters ended
    April 3, 2004     April 2, 2005  
    (Dollars in thousands)  
     
Net commercial product sales
  $ 3,183       100.0 %   $ 3,768       100.0 %
Total cost of commercial product sales
    3,783       118.9 %     4,199       111.4 %
 
                       
Gross profit
  $ (600 )     (18.9 %)   $ (431 )     (11.4 %)
 
                       

     We had a negative gross profit of $431,000 in the first quarter of 2005 from the sale of our commercial products as compared to a negative gross profit of $600,000 in the first quarter of 2004. We experienced negative gross profits in the first quarters of 2004 and 2005 because the reduced level of commercial sales was insufficient to cover our fixed manufacturing overhead costs. Our gross margins were also impacted by charges for excess and obsolete inventory of approximately $90,000 in the first quarter of 2005 and 2004. We regularly review inventory quantities on hand and provided an allowance for excess and obsolete inventory based on numerous factors including sales backlog, historical inventory usage, forecasted product demand and production requirements for the next twelve months. Gross margins in the first quarter of 2005 were favorably impacted by lower manufacturing overhead expenses resulting from our restructuring efforts.

     Contract research and development expenses totaled $683,000 in the first quarter of 2005 as compared to $1.5 million in the first quarter of 2004. These decreases were the result of lower expenses associated with performing a fewer number of government contracts offset by higher expenses associated with completing two contracts.

23


Table of Contents

     Other research and development expenses relate to development of new wireless commercial products. We also incur design expenses associated with reducing the cost and improving the manufacturability of our existing products. These expenses totaled $1.2 million in the first quarter of 2005 as compared to $1.3 million in the same quarter of the prior year. The decrease is due to reduced commercial products development and cost reduction efforts.

     Selling, general and administrative expenses totaled $3.8 million in the first quarter of 2005, as compared to $4.6 million in the first quarter of the prior year. The decrease from 2004 results primarily from lower ISCO litigation expenses, the closure of our Sunnyvale facility and lower expenses resulting from restructuring activities. These decreases were partially offset by higher legal expenses associated with the class action lawsuit and higher expenses related to the retirement benefits to be paid to our former President and Chief Executive Officer.

     During 2004, we implemented several restructuring programs to streamline our operations and reduce our cost structure. We consolidated our Sunnyvale operations into our Santa Barbara facility and reduced our total workforce. The workforce reduction included reductions associated with the Sunnyvale consolidation, as well as other strategic reductions in the organization. In addition, as part of the consolidation, we accelerated a program to implement of a new, lower cost wafer deposition process called Reactive Co-Evaporation.

     During the three months ended April 2, 2005, the Company implemented another restructuring program and reduced its workforce by another 26 positions.

     The following table summarizes our actual restructuring charges for the first quarter of 2005 and our estimated charges for the remainder of 2005 relating to the actions taken in 2004 and the first quarter of 2005:

                 
    Actual     Additional  
    Restructuring     Charges To Be  
    Charges for     Incurred In  
    the First     2005 for Prior  
    Quarter of     Restructuring  
    2005     Activities  
     
Severance costs
  $ 118,000     $  
Facility consolidation costs
    5,000        
Employee relocation cost
    10,000       40,000  
 
           
Total
  $ 133,000     $ 40,000  
Severance costs included in cost of goods sold
    49,000        
 
           
Expense included in operating expenses
  $ 84,000     $ 40,000  
 
           

     Interest income increased in the first quarter of 2005, as compared to the prior year, primarily because we had more cash available for investment.

     Interest expense in the first quarter of 2005 decreased to $39,000, as compared to the prior year, because of lower borrowings.

     We had a net loss of $5.5 million for the quarter ended April 2, 2005, as compared to $5.9 million in the same period last year.

     The net loss available to common shareholders totaled $0.05 per common share in the first quarter of 2005, as compared to $0.09 per common share in the same period last year.

Liquidity and Capital Resources

      Cash Flow Analysis

     As of April 2, 2005, we had working capital of $11.2 million, including $7.5 million in cash and cash equivalents, as compared to working capital of $16.1 million at December 31, 2004, which included $12.8 million in cash and cash equivalents. We currently invest our excess cash in short-term, investment-grade, money-market instruments with maturities of three months or less. We believe that all of our cash investments would be readily available to us should the need arise.

     Cash and cash equivalents decreased by $5.3 million from $12.8 million at December 31, 2004 to $7.5 million at April 2, 2005. Cash was used in operations, for the purchase of property and equipment, for the payment of short and long-term borrowings and for the payment of common stock offering expenses. These uses were partially offset by cash proceeds received

24


Table of Contents

from new borrowings on our line of credit. Cash and cash equivalents decreased by $7.2 million to $3.9 million in the three month period ended April 3, 2004. Cash was used in operations, the purchase of property and equipment payment of short and long-term borrowings. These uses were partially offset by cash proceeds received from new borrowings on our line of credit and cash proceeds from the exercise of options and warrants.

     Cash used in operations totaled $4.2 million in the first quarter of 2005. We used $4.6 million to fund the cash portion of our net loss. We also used cash to fund a $247,000 increases in other assets and accounts payable payments. These uses were offset by cash generated from the collection of accounts receivable and lower inventory and prepaid balances totaling $605,000. Cash used in operations totaled $3.9 million in the first quarter of 2004. We used $5.0 million to fund the cash portion of our net loss. We also used cash to fund a $5.2 million increase in inventory, patents and licenses and other assets and accounts payable payments. Inventory increased in the first quarter of 2004 due to lower than expected sales. These uses were partially offset by cash generated from the collection of accounts receivable and from the decline in other assets which totaled $6.3 million.

     Net cash used in investing activities totaled $33,000 in the first quarter of 2005 as compared to $1.1 million in the first quarter of last year. These expenditures related primarily to purchases of manufacturing equipment and facilities improvements to increase our production capacity.

     Net cash used in financing activities totaled $1.1 million in the first quarter of 2005. Cash used to pay down our line of credit and long term debt totaled $294,000. Cash was also used to pay $797,000 of offering expenses related to the sale of common stock in November 2004. Net cash used in financing activities totaled $2.2 million in the first quarter of 2004. Net payments against our line of credit and payment against our long-term debt totaled $2.7 million. This was partially offset by cash received from the exercise of warrants and options.

      Financing Activities

     We have historically financed our operations through a combination of cash on hand, cash provided from operations, equipment lease financings, available borrowings under bank lines of credit and both private and public equity offerings. We have effective registration statements on file with the SEC covering the public resale by investors of all the common stock issued in our private placements, as well as any common stock acquired upon exercise of their warrants.

     We have an existing line of credit from a bank. It is a material source of funds for our business. The line of credit expires June 15, 2006 The loan agreement is structured as a sale of our accounts receivable and provides for the sale of up to $5.0 million of eligible accounts receivable, with advances to us totaling 80% of the receivables sold. Advances bear interest at the prime rate (5.75% at April 2, 2005) plus 2.50% subject to a minimum monthly charge. Outstanding amounts under this borrowing facility at April 2, 2005 totaled $662,000. The amount outstanding is repaid upon collection of the underlying accounts receivable. Advances are collateralized by a lien on all of our assets. Under the terms of the agreement, we continue to service the sold receivables and are subject to recourse provisions.

      Contractual Obligations and Commercial Commitments

     We incur various contractual obligations and commercial commitments in our normal course of business. They consist of the following:

  •   Capital Lease Obligations

     Our capital lease obligations are for property and equipment and total $70,000 at April 2, 2005.

  •   Operating Lease Obligations

     Our operating lease obligations consist of facility leases in Santa Barbara and Sunnyvale, California. We assumed the Sunnyvale leases in connection with our acquisition of Conductus, Inc. in 2002. At April 2, 2005, the remaining Sunnyvale lease obligations totaled $1.1 million and are due in monthly installments through February 2006. We consolidated the Sunnyvale operations into our Santa Barbara facility in 2004 and recorded a liability for the present value of the remaining obligations under the Sunnyvale leases. We included these liabilities in the financial statements under Accrued Liabilities and Other Long Term Liabilities.

  •   Patents and Licenses

     We have entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Some of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. Typically, the licensor can terminate our license if we fail to pay minimum annual royalties.

  •   Purchase Commitments

     In the normal course of business, we incur purchase obligations with vendors and suppliers for the purchase of inventory, as well as other goods and services. These obligations are generally evidenced by purchase orders that contain the

25


Table of Contents

terms and conditions associated with the purchase arrangements. We are committed to accept delivery of such material pursuant to the purchase orders subject to various contract provisions which allow us to delay receipt of such orders or cancel orders beyond certain agreed upon lead times. Cancellations may result in cancellation costs payable by us.

  •   Quantitative Summary of Contractual Obligations and Commercial Commitments

     At April 2, 2005, we had the following contractual obligations and commercial commitments:

                                         
    Payments Due by Period  
Contractual Obligations   Total     Less than 1 year     2-3 years     4-5 years     After 5 years  
Capital lease obligations
  $ 70,000     $ 38,000     $ 32,000     $     $  
Operating leases
    9,677,000       2,306,000       2,448,000       2,609,000       2,314,000  
Minimum license commitment
    2,250,000       150,000       300,000       300,000       1,500,000  
Fixed asset and inventory purchase commitments
    1,604,000       1,604,000                    
 
                             
Total contractual cash obligations
  $ 13,601,000     $ 4,098,000     $ 2,780,000     $ 2,909,000     $ 3,814,000  
 
                             

      Capital Expenditures

     We plan to invest approximately $450,000 in fixed assets during the remainder of 2005.

      Future Liquidity

     Our principal sources of liquidity consist of existing cash balances and funds expected to be generated from future operations. We believe our existing cash resources, together with our line of credit and a planned inventory reduction, will be sufficient to fund our planned operations for at least the next twelve months. We have more inventory than required for current sales volumes and plan to use our excess inventory as a material source of funding in 2005. We believe the key factors to our liquidity in 2005 will be our ability to successfully execute on our plans to increase sales levels and to convert excess inventory to cash. There is no assurance that the Company will be able to increase sales levels or to sell excess inventory, Our cash requirements will also depend on numerous other variable factors, including the rate of growth of sales, the timing and levels of products purchased, payment terms and credit limits from manufacturers, and the timing and level of accounts receivable collections.

     If actual cash flows deviate significantly from forecasted amounts, we may require additional financing in the next twelve months. We cannot assure you that additional financing (public or private) will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.

     In the last several years, we have raised money from investors to cover our operating losses through public and private offerings. Our ability to continue to raise funds using these methods may be adversely impacted by NASDAQ listing issues. Our continued NASDAQ listing requires us to maintain a minimum stock price of $1 per share. Our stock traded below $1 per share for 30 consecutive business days prior to April 4, 2005. We received a notice of potential delisting from the Nasdaq Stock Market on that date and have been provided until October 3, 2005 to regain compliance with the NASDAQ minimum price rule. If we cannot demonstrate compliance with the minimum price rule by that date, we may request a transfer to the Nasdaq SmallCap Market (presuming we continue to meet the initial listing criteria except for the minimum price requirement) and secure an additional 180 calendar day compliance period which is typically provided to SmallCap issuers. In order to maximize our options for addressing this problem, we are submitting a request to our stockholders at the 2005 annual meeting for discretionary authority over the next year to implement a reverse stock split in the range of 1-for-2 to 1-for-10. The annual meeting is scheduled for May 25, 2005, and we have mailed our proxy statement to the stockholders.

     Our financial statements have been prepared assuming that the Company will continue as a going concern. The factors described above raise substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might result from this uncertainty.

     Our independent registered public accounting firm has included in their audit report for fiscal 2004 an explanatory paragraph expressing doubt about our ability to continue as a going concern. They included a similar explanatory paragraph in their audit report for 2002 and 2003. In 2004, we incurred a net loss of $31.2 million and had negative cash flows from operations of $21.6 million. In response, we reduced direct and indirect labor and continued to cut fixed costs. We also

26


Table of Contents

consolidated our Sunnyvale operations into our Santa Barbara facility and accelerated the implementation of a new, lower cost wafer deposition process. In the first quarter of 2005 we incurred a net loss of $5.5 million and had negative cash flows from operations of $4.2 million. We are continuing to look for opportunities to reduce expenses and generate cash.

Net Operating Loss Carryforward

     As of December 31, 2004, we had net operating loss carryforwards for federal and state income tax purposes of approximately $244.6 million and $119.4 million, respectively, which expire in the years 2005 through 2024. Of these amounts $93.7 million and $30.2 million, respectively resulted from the acquisition of Conductus. Included in the net operating loss carryforwards are deductions related to stock options of approximately $24.1 million and $13.1 million for federal and California income tax purposes, respectively. To the extent net operating loss carryforwards are recognized for accounting purposes the resulting benefits related to the stock options will be credited to stockholders’ equity. In addition, we have research and development and other tax credits for federal and state income tax purposes of approximately $2.6 million and $2.4 million, respectively, which expire in the years 2005 through 2024. Of these amounts $972,000 and $736,000, respectively resulted from the acquisition of Conductus.

     Due to the uncertainty surrounding their realization, we have recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying balance sheet.

     Section 382 of the Internal Revenue Code imposes an annual limitation on the utilization of net operating loss carryforwards based on a statutory rate of return (usually the “applicable federal funds rate”, as defined in the Internal Revenue Code) and the value of the corporation at the time of a “change of ownership” as defined by Section 382. We completed an analysis of our equity transactions and determined that we had a change in ownership in August 1999 and December 2002. Therefore, the ability to utilize net operating loss carryforwards incurred prior to the change of ownership totaling $101.6 million will be subject in future periods to an annual limitation of $1.3 million. In addition, we acquired the right to Conductus’ net operating losses, which are also subject to the limitations imposed by Section 382. Conductus underwent three ownership changes, which occurred in February 1999, February 2001 and December 2002. Therefore, the ability to utilize Conductus’ net operating loss carryforwards of $93.7 million incurred prior to the ownership changes will be subject in future periods to annual limitation of $700,000. Net operating losses incurred by us subsequent to the ownership changes totaled $51.4 million and are not subject to this limitation.

Future Accounting Requirements

     In December 2004, the Financial Accounting Standards Board issued SFAS No. 123(R) (revised 2004), “Share-Based Payment” which amends SFAS Statement 123 and will be effective for public companies for annual periods beginning after June 15, 2005. The new standard will require us to recognize compensation costs in our financial statements in an amount equal to the fair value of share-based payments granted to employees and directors. We are currently evaluating how we will adopt the standard and evaluating the effect that the adoption of SFAS 123(R) will have on our financial position and results of operations

     In November 2004, the FASB issued SFAS No. 151, “Inventory Costs”, and amendment of ARB No. 43, Chapter 4. This statement amends the guidance in ARB No. 43, Chapter 4, Inventory Pricing, to clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). Paragraph 5 of ARB No. 43, Chapter 4, previously stated that “...under some circumstances, items such as idle facility expense, excessive spoilage, double freight, and rehandling costs may be so abnormal as to require treatment as current period charges....” SFAS No. 151 requires that those items be recognized as current-period charges regardless of whether they meet the criterion of “so abnormal.” In addition, this statement requires that allocation of fixed production overheads to the cost of conversion be based on the normal capacity of the production facilities. The provisions of SFAS 151 shall be applied prospectively and are effective for inventory costs incurred during fiscal years beginning after June 15, 2005, with earlier application permitted for inventory costs incurred during fiscal years beginning after the date this Statement was issued. We do not expect the adoption of SFAS No. 151 to have a material impact on our financial position and results of operations.

Forward-Looking Statements

     This report contains forward-looking statements that involve risks and uncertainties. We have made these statements in reliance on the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements relate to future events or our future performance and include, but are not limited to, statements concerning our business strategy, future commercial revenues, market growth, capital requirements, new product introductions, expansion plans and the adequacy of our funding. Other statements contained in this report that are not historical facts are also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and other comparable terminology.

27


Table of Contents

     Forward-looking statements are not guarantees of future performance and are subject to various risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may differ materially from those expressed in forward-looking statements. They can be affected by many factors, including, but not limited to the following:

  •   fluctuations in product demand from quarter to quarter which can be significant,
 
  •   the impact of competitive filter products, technologies and pricing,
 
  •   manufacturing capacity constraints and difficulties,
 
  •   market acceptance risks, and
 
  •   general economic conditions.

     Please read the section in our 2004 Annual Report on Form 10-K entitled “ Business — Additional Factors That May Affect Our Future Results ” for a description of additional uncertainties and factors that may affect our forward-looking statements. Forward-looking statements are based on information presently available to senior management, and we do not assume any duty to update our forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     There was no material change in our exposure to market risk at April 2, 2005 as compared with our market risk exposure on December 31, 2004. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Market Risk” in our 2004 Annual Report on Form 10-K.

Item 4. Disclosure Controls and Procedures.

      Evaluation of Disclosure Controls and Procedures

     Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit, is recorded, processed, summarized and reported, within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms. Our Chief Executive Officer and Chief Financial Officer have evaluated our disclosure controls and procedures and have concluded that they were effective as of April 2, 2005.

      Changes in Internal Controls

     There has been no change in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d) – 15(f)) during the first quarter of 2005 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Patent Litigation

     The Company was engaged in a patent dispute with ISCO International, Inc. relating to U.S. Patent No. 6,263,215 entitled “Cryoelectronically Cooled Receiver Front End for Mobile Radio Systems.” ISCO filed a complaint on July 17, 2001 in the United States District Court for the District of Delaware against us and our wholly-owned subsidiary, Conductus, Inc. The ISCO complaint alleged that our SuperFilter product and Conductus’ ClearSite® product infringe ISCO’s patent. The matter went to trial on March 17, 2003.

     On April 3, 2003, the jury returned a unanimous verdict that our SuperFilter product does not infringe the patent in question, and that ISCO’s patent is invalid and unenforceable. The jury also awarded us $3.8 million in compensatory damages based upon a finding that ISCO engaged in unfair competition and acted in bad faith by issuing press releases and contacting our customers asserting rights under this patent.

28


Table of Contents

     On April 17, 2003, the Company filed a Motion for Attorneys’ Fees and Disbursements, in which it asked the court to award it it’s attorneys’ fees and other litigation expenses. On the same date, ISCO filed a motion, asking the court to overturn the verdict and grant a new trial. In August 2003, the court rejected ISCO’s request to overturn the jury’s verdict that the patent is invalid and not infringed by the SuperFilter product, and accepted the jury’s verdict that the patent is unenforceable because of inequitable conduct committed by one of the alleged inventors. ISCO subsequently filed a notice of appeal as to this portion of the court’s decision. The court overturned the jury’s verdict of unfair competition and bad faith on the part of ISCO and the related $3.8 million compensatory damage award to us, and also denied our request for reimbursement of our legal fees associated with the case. The Company filed a notice of appeal as to this portion of the court’s decision.

     On February 3, 2005, the Appellate Court reaffirmed the unanimous jury verdict that ISCO’s US patent is invalid and unenforceable. The Appellate Court also denied the Company’s request to reinstate the jury’s $3.8 million damage award to us for unfair competition and bad faith on the part of ISCO. The trial judge had overruled the jury’s finding on this point, and the Company appealed that portion of the judge’s ruling.

Class Action Lawsuits

     The Company and certain of it’s officers were named as a defendant in several substantially identical class action lawsuits filed in the United States District Court for the Central District of California in April 2004. The cases were consolidated in August 2004, and the plaintiffs filed an amended consolidated complaint in October 2004. The plaintiffs allege securities law violations by us and certain of our officers and directors under Rule 10b-5 and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended. The complaint was filed on behalf of a purported class of people who purchased our stock during the period between January 9, 2004 and March 1, 2004 and seeks unspecified damages. The plaintiffs base their allegations primarily on the fact that the Company did not achieve its forecasted revenue guidance of $10 to $13 million for the first quarter of 2004.

     In February 2005 the Company settled with the lead plaintiffs appointed by the District Court to handle this matter. Under the terms of the settlement, the Company’s insurers will pay $4.0 million into a settlement fund, and the Company will pay up to $50,000 of the costs of providing notice of the settlement to settlement class members. The settlement remains subject to approval by the District Court. The Company recorded a liability in its December 31, 2004 consolidated financial statements for the proposed amount of the settlement of $4,050,000. Because the insurance carrier involved in this suit agreed to pay $4.0 million of the settlement amount, and therefore recovery from the insurance carrier was probable, a receivable was also recorded for that amount. These amounts were paid into the settlement fund in April 2005.

Item 5. Other Information

(a) Additional Disclosures

     None

(b) Stockholder Nominations

     There have been no material changes to the procedures by which stockholders may recommend nominees to our board of directors. Please see the discussion of our procedures under the heading “Board Meetings and Committees” on pages 4 and 5 of our 2005 Proxy Statement available online at www.sec.gov .

Item 6. Exhibits

           
 
  Number     Description of Document  
 
3.1
    Amended and Restated Certificate of Incorporation of the Company (1)  
 
3.2
    Certificate of Amendment of Restated Certificate of Incorporation (2)  
 
3.3
    Bylaws of the Registrant (3)  
 
3.4
    Certificate of Amendment of Bylaws dated May 17, 2001 (2)  
 
3.5
    Certificate of Amendment of Bylaws dated August 8, 2001 (2)  
 
4.1
    Form of Common Stock Certificate (4)  
 
4.2
    Third Amended and Restated Stockholders Rights Agreement (3)  
 

29


Table of Contents

           
 
  Number     Description of Document  
 
4.3
    Warrant Issued to PNC Bank, National Association in connection with Credit Agreement (3)  
 
4.4
    Registration Rights Agreement to United States Cellular Corporation (5)  
 
4.5
    Form of Warrant to United States Cellular Corporation (5)  
 
4.6
    Warrant Purchase Agreement dated December 1, 1999 with PNC Bank (6)  
 
4.7
    Warrant Purchase Agreement dated January 12, 2000 with PNC Bank (6)  
 
4.8
    Certificate of Designations, Preferences and Rights of Series E Convertible Stock (7)  
 
4.9
    Securities Purchase Agreement dated as of September 29, 2000 between the Company and RGC International Investors, LDC. (Exhibits and Schedules Omitted) (7)  
 
4.10
    Registration Rights Agreement dated as of September 29, 2000 between the Company and RGC International Investors, LDC. (7)  
 
4.11
    Initial Stock Purchase Warrant dated as of September 29, 2000 between the Company and RGC International Investors, LDC. (7)  
 
4.12
    Incentive Stock Purchase Warrant dated as of September 29, 2000 between the Company and RGC International Investors, LDC. (7)  
 
4.13
    Registration Rights Agreement, dated March 6, 2002 (8)  
 
4.14
    Warrants to Purchase Shares of Common Stock, dated March 11, 2002 (8)  
 
4.15
    Registration Rights Agreement dated October 10, 2002 (9)  
 
4.16
    Warrants to Purchase Common Stock dated October 10, 2002 (9)  
 
4.17
    Common Stock Purchase Agreement, dated March 8, 2002 between Conductus, Inc. and the investors signatory thereto (10)  
 
4.18
    Warrant to Purchase Common Stock, dated March 8, 2002 by Conductus, Inc. to certain investors (11)  
 
4.19
    Registration Rights Agreement, dated March 26, 2002, between Conductus, Inc. and certain investors (11)  
 
4.20
    Warrant to Purchase Common Stock, dated August 7, 2000, issued by Conductus to Dobson Communications Corporation (12) *  
 
4.21
    Form of Series B Preferred Stock and Warrant Purchase Agreement dated September 11, 1998 and September 22, 1998 between Conductus and Series B Investors (13)  
 
4.22
    Form of Warrant to Purchase Common Stock between Conductus and Series B investors, dated September 28, 1998, issued by Conductus in a private placement (13)  
 
4.23
    Form of Series C Preferred Stock and Warrant Purchase Agreement, dated December 10, 1999, between Conductus and Series C Investors (14)  
 
4.24
    Form of Warrant Purchase Common Stock between Conductus and Series C investors, dated December 10, 1999, issued by Conductus in a private placement (14)  
 
4.25
    Form of Warrant to Purchase Common Stock dated March 28, 2003, issued to Silicon Valley Bank (15)  
 
4.26
    Form of Warrant (16)  
 
4.27
    Form of Registration Rights Agreement (16)  
 
4.28
    Agility Capital Warrant dated May 2004 (17)  
 
4.29
    Silicon Valley Bank Warrant dated May 2004(17)  
 
10.1
    Employment Agreement with Terry White  
 
10.2
    Non-Employee Director Compensation Plan  
 
10.3
    Accounts Receivable Purchase Modification Agreement with Silicon Valley Bank dated March 29, 2005 (18)  
 
10.4
    Settlement Agreement – Class Action  
 
31.1
    Statement of CEO Pursuant to 302 of the Sarbanes-Oxley Act of 2002  
 
31.2
    Statement of CFO Pursuant to 302 of the Sarbanes-Oxley Act of 2002  
 
32.1
    Statement of CEO Pursuant to 906 of the Sarbanes-Oxley Act of 2002  
 
32.2
    Statement of CFO Pursuant to 906 of the Sarbanes-Oxley Act of 2002  
 


(1)   Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed for the quarter ended April 3, 1999.
 
(2)   Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed for the quarter ended June 30, 2001.
 
(3)   Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed for the quarter ended July 3, 1999.

30


Table of Contents

(4)   Incorporated by reference from the Registrant’s Registration Statement on Form S-1 (Reg. No. 33-56714).
 
(5)   Incorporated by reference from the Registrant’s Quarterly Report on Form 10-Q filed for the quarter ended October 2, 1999.
 
(6)   Incorporated by reference from the Registrant’s Registration Statement on Form S-8 (Reg. No. 333-90293).
 
(7)   Incorporated by reference from the Registrant’s Annual Report on Form 10-K for the year ended December 31, 1999.
 
(8)   Incorporated by reference from Registrant’s Annual Report on Form 10-K for the year ended December 31, 2001.
 
(9)   Incorporated by reference from the Registrant’s Current Report on Form 8-K, filed October 2, 2002.
 
(10)   Incorporated by reference from the Registrant’s Annual Report on Form 10-K filed for the year ended December 31, 1997.
 
(11)   Incorporated by reference from the Conductus, Inc.’s Registration Statement on Form S-3 (Reg. No. 333-85928), filed on April 9, 2002.
 
(12)   Incorporated by reference from Conductus, Inc.’s Quarterly Report on Form 10-Q, filed with the SEC on November 16, 1998.
 
(13)   Incorporated by reference from Conductus, Inc.’s Annual Report on Form 10-K, filed with the SEC on March 30, 2000.
 
(14)   Incorporated by reference from Conductus, Inc.’s Annual Report on Form 10-K for the year ended December 31, 1999.
 
(15)   Incorporate by reference from Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 29, 2003.
 
(16)   Incorporated by reference from Registrant’s Current Report on Form 8-K filed June 25, 2003.
 
(17)   Incorporated by reference from Registrants’ Registration Statement of Form S-3 Reg. 333-89184).
 
(18)   Incorporated by reference from Registrants’ Form 8-K dated March 29, 2005
 

*   Confidential treatment has been previously granted for certain portions of these exhibits.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

             
      SUPERCONDUCTOR TECHNOLOGIES INC .    
 
Dated: May 6, 2005
      /s/ Martin S. McDermut    
     
      Martin S. McDermut    
      Senior Vice President, Chief Financial Officer and Secretary    
 
           
      /s/ Jeffrey A. Quiram    
     
      Jeffrey A. Quiram    
      President and Chief Executive Officer    

 

 

Exhibit 10.1

Superconductor Technologies Inc.

EMPLOYMENT AGREEMENT

     This Employment Agreement (the “ Agreement ”) is made and entered into as of April 11, 2005, by and between Superconductor Technologies Inc., a Delaware corporation (the “ Company ”), and Terry White, an individual (the “ Executive ”), with reference to the following facts:

     A. The Company, headquartered in Santa Barbara, California, is the global leader in developing, manufacturing, and marketing superconducting products for wireless networks.

     B. Executive is an executive with broad sales experience in the telecommunications industry.

     C. The Company wishes to hire Executive for the position of Vice President of Worldwide Sales, and Executive wishes to be hired for such position, on the terms and conditions set forth in this Agreement.

     NOW, THEREFORE, based on the above premises and in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

     1.  Employment with the Company .

          1.1 Position and Duties . Subject to the terms set forth herein, the Company agrees to employ Executive as Vice President of Worldwide Sales, and Executive hereby accepts such employment. Executive shall serve in an executive capacity and shall perform such duties as are customarily associated with his position, consistent with the Restated Bylaws of the Company and as reasonably required by the Company’s Board of Directors (the “ Board ”). Executive will report to the Company’s President and Chief Executive Officer.

          1.2 Full Time and Best Efforts . Executive will perform his duties faithfully and to the best of his ability and will devote his full business time and effort to the performance of his duties hereunder. Executive will not engage in any other employment or business activities for any direct or indirect remuneration that would be directly harmful or detrimental to, or that may compete with, the business and affairs of the Company, or that would interfere with his duties hereunder. Executive acknowledges that frequent travel may be necessary in carrying out his duties hereunder

          1.3 Company Policies . The employment relationship between the parties shall be governed by the general employment policies and practices of the Company, including but not limited to those relating to protection of confidential information and assignment of inventions, except that when the terms of this Agreement differ from or are in conflict with the Company’s general employment policies or practices, this Agreement shall control. This Agreement shall not be effective until the Executive signs the Company’s standard Employee Proprietary Information Agreement.

     2.  At-Will Employment . Executive’s employment with the Company is “at-will” and may be terminated at any time without cause by either party. Termination of the employment relationship is the right of each party and will not constitute a breach of this Agreement. No provision of this Agreement shall be construed as conferring upon Executive a right to continue as an employee or executive of the Company or any subsidiary or affiliated entity. In the event

 


 

of termination, Executive will voluntarily and immediately resign from any and all director and officer positions he may hold with the Company and subsidiary or affiliate.

     3.  Compensation .

          3.1 Base Salary . The Company will compensate Executive for services rendered hereunder at the rate of Two Hundred Twenty Thousand Dollars ($220,000) per year payable in accordance with the Company’s normal payroll practices and subject to payroll deductions as may be necessary or customary for the Company’s salaried employees. The Compensation Committee of the Board (the “ Compensation Committee ”) will review, and in its sole discretion may increase, the Base Salary each year.

          3.2 Performance Bonus . The Company will pay Executive an annual performance bonus based upon achievement of performance goals. The sales incentive bonus for 2005 shall be based on a mutually acceptable revenue plan for net commercial product sales as follows:

     
    Net Commercial    
    Product Sales   Bonus Formula
      (% of Plan)   (Percentage of Base Salary)
 
Less than 70%
  0%
 
   
70% to 100%
  10% to 30% (linear scale)
 
   
Over 100%
  2.0% of the amount by which net
 
  commercial product sales exceed plan

     The term “net commercial product sales” shall mean the actual net commercial product sales for 2005 as finally determined and set forth in the Company’s audited financial statements. The foregoing sales targets and bonus payments are for the full year 2005 and will be pro rated based on Executive’s actual start date. The bonus structure for future years is to be mutually agreed upon.

          3.3 Equity Incentive Compensation .

               3.3.1 Option Grants . The Company will grant Executive a non-qualified stock option under its 2003 Equity Incentive Plan to purchase One Million (1,000,000) shares of common stock with a per share exercise price equal to the fair market value of the Company’s common stock on the date the stockholders approve an increase in the number of shares of stock authorized for grants under the 2003 Equity Incentive Plan.

               3.3.2 Other Terms . All of the options granted under this Section 3.3 will (a) have a term of ten (10) years, (b) vest 25% on the first anniversary of Executive’s start date with the Company and 75% in 36 equal monthly installments thereafter, (c) have such other terms as are contained in the Company’s standard form of stock option agreement presently in use and not inconsistent with the terms of this Agreement and (d) be subject to all the terms and conditions of the Company’s 2003 Equity Incentive Plan.

               3.3.3 Stockholder Approval of Plan Increase . The Company will submit a request to its stockholders at the upcoming 2005 annual meeting to increase the number of shares of stock authorized for grants under the 2003 Equity Incentive Plan. If the stockholders decline to approve the increase, the Company will grant options to the Company’s CEO and to Executive under the 2003 Equity Plan (priced with a per share exercise price equal to the fair market value of the Company’s common stock on the date the stockholders decline to approve the increase) as and when additional options become available under the plan as a result of the

2


 

expiration and forfeiture of other stock options outstanding under the plan until is has fulfilled its obligations to CEO and to Executive under Section 3.3.1. The Company will allocate shares from each available grant sixty percent (60%) to the CEO and forty percent (40%) to Executive. The Company will not grant any further stock options under the 2003 Equity Incentive Plan until it has fulfilled its obligations to the CEO and to Executive under Section 3.3.1.

     4.  Benefits . Executive shall be entitled to participate in the employee benefit plans and programs of the Company, if any, to the extent that his position, tenure, salary, age, health and other qualifications make him eligible to participate in such plans or programs, subject to the rules and regulations applicable thereto. Subject to Section 10.5.4, the Company reserves the right to cancel or change the benefit plans and programs it offers to its employees at any time.

     5.  Business Expenses . The Company shall reimburse Executive for reasonable travel, entertainment or other expenses incurred by Executive in the furtherance of or in connection with the performance of Executive’s duties hereunder, in accordance with the Company’s expense reimbursement policy as in effect from time to time.

     6.  Termination Before a Change of Control .

          6.1 Involuntary Termination . If Executive’s employment with the Company is terminated before a Change of Control due to an Involuntary Termination, then Executive shall be entitled to receive the following:

               6.1.1 a severance payment equal to six (6) months of Executive’s Base Salary as in effect on the date of the Involuntary Termination, paid in accordance with then prevailing payroll practice; and

               6.1.2 six (6) months of coverage for Executive and his spouse/dependents under group health, life or other similar insurance plans substantially comparable to the group health, life and other similar insurance plans in which Executive and his spouse/dependents participated on the date of such termination,

          6.2 Other Termination . If Executive’s employment is terminated before a Change of Control for any reason other than an Involuntary Termination, then Executive shall not be entitled to receive severance or other benefits pursuant to this Agreement, but may be eligible for those benefits (if any) as may then be established under the Company’s severance and benefits plans and policies existing at the time of such termination.

          6.3 Mitigation . The Executive shall not be required to mitigate the amount of any payment or benefit contemplated by this Section 6 (whether by seeking new employment or in any other manner). No such payment shall be reduced by earnings that the Executive may receive from any other source.

     7.  Change of Control .

          7.1 Benefits . In the event of a Change of Control, Executive shall be entitled to receive the following in lieu of any payments or other benefits under Section 6 (Termination Before Change of Control) and regardless of whether Executive’s employment is continued or terminated (except as expressly provided below in Section 7.1.2 and Section 7.1.3):

               7.1.1 accelerated vesting of fifty percent (50%) of Executive’s unvested stock options;

               7.1.2 accelerated vesting of the remaining fifty percent (50%) of Executive’s options if and only if Executive does not resign during the six month period following the date of the Change of Control; and

3


 

               7.1.3 if Executive is terminated due to an Involuntary Termination, then he shall receive a lump sum payment equal to one (1.0) times Executive’s Base Salary as in effect on the date of the Involuntary Termination.

          7.2 Excise Taxes . In the event that it is determined that any payment or distribution of any type to or for the benefit of the Executive made by the Company, by any of its affiliates, by any person who acquires ownership or effective control of the Company or ownership of a substantial portion of the Company’s assets (within the meaning of section 280G of the Internal Revenue Code of 1986, as amended, and the regulations thereunder (the “ Code ”)) or by any affiliate of such person, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “ Total Payments ”), would be subject to the excise tax imposed by section 4999 of the Code or any interest or penalties with respect to such excise tax (such excise tax, together with any such interest or penalties, are collectively referred to as the “ Excise Tax ”), then such payments or distributions shall be limited to such amount which would result in no portion of the payments or distributions being subject to the Excise Tax.

          7.3 Determination of Excise Tax . All mathematical determinations and all determinations of whether any of the Total Payments are “parachute payments” (within the meaning of section 280G of the Code) that are required to be made under Section 7.2, shall be made by Deloitte & Touche LLP (or the Company’s then current tax accounting firm) (the “ Tax Firm ”), who shall provide their determination (the “ Determination ”), together with detailed supporting calculations regarding the amount of any relevant matters, both to the Company and to the Executive within seven (7) business days of the Executive’s termination date, if applicable, or such earlier time as is requested by the Company or by the Executive. If applicable, the Tax Firm shall furnish the Executive with a written statement that it has concluded that no Excise Tax is payable (including the reasons therefor) and that the Executive has substantial authority not to report any Excise Tax on the Executive’s federal income tax return. Any determination by the Tax Firm shall be binding upon the Company and the Executive, absent manifest error. The Company shall pay the fees and costs of the Tax Firm.

     8.  Condition to Severances Payments . All severance payments and other benefits provided under Sections 6 and 7 are conditioned on Executive’s continuing compliance with this Agreement and the Company’s policies and Executive’s execution of a release of claims and covenant not to sue substantially in the form provided in Exhibit A upon termination of employment .

     9.  Indemnification . The Company and Executive will concurrently herewith execute an Indemnification Agreement identical in form and substance to the Indemnification Agreement currently in effect for the Company’s other Executive Officers.

     10.  Definitions .

          10.1 Base Salary . “Base Salary” means Executive’s annualized base salary under Section 3.1 and as may be subsequently adjusted upward for increases.

          10.2 Cause . “Cause” means the occurrence of anyone or more of the following:

               10.2.1 Executive’s conviction by, or entry of a plea of guilty or nolo contendere in, a court of final jurisdiction for any crime which constitutes a felony in the jurisdiction involved;

4


 

               10.2.2 Executive’s misappropriation of funds or commission of an act of fraud, whether prior or subsequent to the date hereof, upon the Company;

               10.2.3 willful disregard by Executive in the scope of Executive’s services to the Company;

               10.2.4 a breach by Executive of a material provision of this Agreement;

               10.2.5 a failure of Executive to substantially perform his duties hereunder; or

               10.2.6 a failure of Executive to follow the lawful mandates of the Board.

     Notwithstanding the foregoing, Executive shall not be deemed to have been terminated for Cause without (a) reasonable notice to Executive setting forth the reasons for Company’s intention to terminate for Cause and (b) an opportunity for Executive to be heard before the Board.

          10.3 Change of Control . “Change of Control” means the occurrence of any of the following events on or after the effective date of this Agreement:

               10.3.1 When any “person,” as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of the Company representing thirty percent (30%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote generally in the election of directors, other than the following persons:

                    10.3.1.1 the Company,

                    10.3.1.2 a subsidiary of the Company,

                    10.3.1.3 a Company employee benefit plan, including any trustee of such plan acting as trustee, or

                    10.3.1.4 any person who, as of the effective date of this Agreement, has publicly disclosed in filings with the Securities and Exchange Commission the beneficial ownership of more than 5% of the combined voting power of the Company’s outstanding securities entitled to vote generally in the election of directors;

               10.3.2 The stockholders of the Company approve a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Company approve an agreement for the sale or disposition by the Company of all or substantially all the Company’s assets;

               10.3.3 A change in the composition of the Board of Directors of the Company, as a result of which fewer than a majority of the directors are Incumbent Directors. “ Incumbent Directors ” shall mean directors who either (a) are directors of the Company as of the effective date of this Agreement, or (b) are elected, or nominated for election, to the Board of Directors of the Company with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company);

5


 

               10.3.4 The sale, transfer or other disposition of all or substantially all of the Company’s assets; or

               10.3.5 The stockholders of the Company approve the dissolution or liquidation of the Company.

          10.4 “ Executive Officer ” shall have the meaning set forth in Rule 3b-7 under the Securities Exchange Act of 1934, as amended.

          10.5 Involuntary Termination . “Involuntary Termination” means the occurrence of any one or more of the following:

               10.5.1 without Executive’s express written consent, a material reduction of Executive’s duties or responsibilities relative to Executive’s duties or responsibilities in effect immediately prior to such reduction, or the removal of Executive from such duties and responsibilities, unless Executive is provided with comparable duties and responsibilities over the same business unit;

               10.5.2 without Executive’s express written consent, a material reduction of the facilities and perquisites (including office space and location) available to Executive immediately prior to such reduction;

               10.5.3 without Executive’s express written consent, a reduction by the Company of Executive’s Base Salary in effect immediately prior to such reduction, unless it occurs in connection with a restructuring or other cost-cutting measure as evidenced by a comparable reduction in the base salary of all Executive Officers;

               10.5.4 a material reduction by the Company in the kind or level of employee benefits to which the Executive is entitled immediately prior to such reduction with the result that the Executive’s overall benefits package is significantly reduced;

               10.5.5 any purported termination of the Executive by the Company which is not effected for Cause or for which the grounds relied upon are not valid; or

               10.5.6 the failure of the Company to obtain the assumption of this Agreement by any successors contemplated in Section 12.

The conversion of the Company into a subsidiary, division or other business unit of any successor entity shall not constitute a triggering event under Section 10.5.1 provided Executive has substantially the same duties and responsibilities over such subsidiary, division or other business unit immediately before and after such conversion.

     11.  Advice of Counsel . Executive acknowledges that he has been represented by counsel in the negotiation of this Agreement and is fully aware of his rights and obligations under this Agreement.

     12.  Successors .

          12.1 Company’s Successors . Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “ Company ,” shall include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this Section 12.1 or which becomes bound by the terms of this Agreement by operation of law.

6


 

          12.2 Executive’s Successors . Without the written consent of the Company, Executive shall not assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity. Notwithstanding the foregoing, the terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

     13.  Notice Clause .

          13.1 Manner . Any notice hereby required or permitted to be given shall be sufficiently given if in writing and upon mailing by registered or certified mail, postage prepaid, to either party at the address of such party or such other address as shall have been designated by written notice by such party to the other party .

          13.2 Effectiveness . Any notice or other communication required or permitted to be given under this Agreement will be deemed given on the day when delivered in person, or the business day after the day on which such notice was mailed in accordance with Section 13.1.

     14.  Governing Law . This Agreement shall be governed by and construed in accordance with the internal substantive laws, but not the choice of law rules, of the state of California.

     15.  Arbitration . Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be settled by arbitration in Los Angeles in accordance with the Commercial Arbitration Rules of the American Arbitration Association. Discovery shall be permitted to the same extent as in a proceeding under the Federal Rules of Civil Procedure, including (without limitation) such discovery as is specifically authorized by section 1283.05 of the California Code of Civil Procedure, without need of prior leave of the arbitrator under section 1283.05(e) of such Code. Judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The Company shall bear the expense of the arbitrator.

     16.  Attorneys’ Fees for Executive . The Company will reimburse Executive for up to $2,000 of legal fees and costs incurred by Executive in connection with the negotiation of this Agreement. Further, if any litigation or arbitration is commenced (including any proceedings in a bankruptcy court) between the parties concerning any provision of this Agreement and Executive is the prevailing party in such proceeding, the Executive shall be entitled, in addition to such other relief as may be granted, to recover his attorneys’ reasonable fees and costs incurred by reason of such litigation or arbitration. The prevailing party shall be determined by the court or arbitrator based upon an assessment of which party’s major arguments or positions taken in the proceedings could fairly be said to have prevailed over the other party’s major arguments or positions on major disputed issues.

     17.  Severability . The invalidity or unenforceability of any provision of this Agreement, or any terms hereof, shall not affect the validity or enforceability of any other provision or term of this Agreement.

     18.  Confidentiality and Trading Restrictions . The parties agree the existence and negotiation of this Agreement, and any non-public information exchanged in connection therewith, are confidential (collectively, “ Confidential Information ”). They will not disclose any Confidential Information except as provided herein. Either party may disclose Confidential Information to its employees and advisors who are required to have the information for the purpose of providing assistance in the negotiations. The Company may disclose the existence of the negotiations and this Agreement at such time as it determines public disclosure is required under the applicable securities laws. The parties will not use any Confidential

7


 

Information except for the decision whether to enter into an employment relationship and negotiating the terms of employment. Executive will refrain from trading in the Company’s securities until 72 hours after public disclosure by Company of this Agreement. Thereafter, Executive may trade in the Company’s securities only in compliance with the Company’s Insider Trading Policy.

     19.  Integration . This Agreement and any other agreement referred to herein or executed contemporaneously herewith represent the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral. No waiver, alteration, or modification of any of the provisions of this Agreement shall be binding unless in writing and signed by duly authorized representatives of the parties hereto.

     20.  Taxes . All payments made pursuant to this Agreement shall be subject to withholding of applicable income and employment taxes.

     21.  Counterparts and Facsimile . This Agreement may be executed in counterparts and by facsimile.

*** [NEXT PAGE IS SIGNATURE PAGE] ***

8


 

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed, as of the day and year first above written.

     
Executive   Company
 
  SUPERCONDUCTOR TECHNOLOGIES INC.
 
   
 
   
Terry White
  Jeffrey A. Quiram, President and Chief Executive Officer

S-1


 

EXHIBIT A

Form of Release of Claims and Covenant Not To Sue

     In consideration of the payments and other benefits that Superconductor Technologies Inc. (the “ Company ”) is providing to ____________(“ Executive ”) under the Employment Agreement entered into by and between Executive and the Company, dated April ___, 2005, the Executive, on his/her own behalf and on behalf of Executive’s representatives, agents, heirs and assigns, waives, releases, discharges and promises never to assert any and all claims, demands, actions, costs, rights, liabilities, damages or obligations of every kind and nature, whether known or unknown, suspected or unsuspected that Executive ever had, now have or might have as of the date of Executive’s termination of employment with the Company against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, attorneys, insurers, successors, or assigns (including all such persons or entities that have a current and/or former relationship with the Company) (the “ Released Parties ”) for any claims arising from or related to Executive’s employment with the Company, its parent or any of its affiliates and subsidiaries and the termination of that employment.

     These released claims also specifically include, but are not limited to, any claims arising under any federal, state and local statutory or common law, such as (as amended and as applicable) Title VII of the Civil Rights Act, the Age Discrimination in Employment Act, the Americans With Disabilities Act, the Employee Retirement Income Security Act, the Family Medical Leave Act, the Equal Pay Act, the Fair Labor Standards Act, the Industrial Welfare Commission’s Orders, the California Fair Employment and Housing Act, the California Constitution, the California Government Code, the California Labor Code and any other federal, state or local constitution, law, regulation or ordinance governing the terms and conditions of employment or the termination of employment, and the law of contract and tort and any claim for attorneys’ fees; provided, however, that Executive does not release or discharge the Released Parties from (i) any of the Company’s obligations to him under the Employment Agreement, and (ii) any vested benefits to which he may be entitled under any employee benefit plan or program subject to ERISA.

     Furthermore, the Executive acknowledges that this waiver and release is knowing and voluntary and that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled. Executive acknowledges that there may exist facts or claims in addition to or different from those which are now known or believed by Executive to exist. Nonetheless, this Agreement extends to all claims of every nature and kind whatsoever, whether known or unknown, suspected or unsuspected, past or present. Executive also expressly waives the provisions of California Civil Code section 1542, which provides: “A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him/her must have materially affected his settlement with the debtor.” With respect to the claims released in the preceding sentences, the Executive will not initiate or maintain any legal or administrative action or proceeding of any kind against the Company or its predecessors, parent, affiliates, subsidiaries, stockholders, owners, directors, officers, employees, agents, successors, or assigns (including all such persons or entities that have a current or former relationship with the Company), for the purpose of obtaining any personal relief, nor assist or participate in any such proceedings, including any proceedings brought by any third parties (except as otherwise required or permitted by law). The Executive further acknowledges that he/she has been advised by this writing that:

A-1


 

  •   he/she should consult with an attorney prior to executing this release;
 
  •   he/she has at least twenty-one (21) days within which to consider this release;
 
  •   he/she has up to seven (7) days following the execution of this release by the parties to revoke the release; and
 
  •   this release shall not be effective until such seven (7) day revocation period has expired.

     Executive agrees that the release set forth above shall be and remain in effect in all respects as a complete general release as to the matters released.

     
EXECUTIVE
   
 
   
                                                              
  Date:                                          

A-2

 

Exhibit 10.2

Superconductor Technologies Inc.

Compensation Policy for Non-Employee Directors

(March 18, 2005)

I. Introduction

     Similar to its philosophy for the compensation of executive officers, the Board of Directors (the Board ) of Superconductor Technologies Inc. (the “ Company ”) believes that the Company’s future success depends in part on its ability to attract and retain highly qualified individuals to serve on the Board. With this goal in mind, the Board periodically reviews the compensation arrangements for non-employee directors. Based on those reviews and the consideration of director compensation practices at comparable companies, the Board has from time to time approved certain compensation policies and practices which it believes are necessary to maintain a competitive compensation package for its non-employee directors. The Board has further concluded that it would be appropriate and useful to consolidate and formalize those policies and practices in one comprehensive document.

II. Scope of Policy

     This policy governs the compensation of non-employee directors of the Company. For purposes of this policy, a “ non-employee director ” means a director who (i) is not employed as an officer or other employee of the Company or any of its subsidiaries and (ii) does not receive more than $60,000 in compensation, directly or indirectly, in the relevant year from the Company or any of its subsidiaries for services as a consultant or in any other capacity other than as a director.

III. Board Fees .

     A.  Annual Retainer . Non-employee directors will receive an annual retainer of $10,000 per year provided the director attends at least 75% of the regular meetings of the Board. Attendance may be in person or by telephone, but attendance in person is encouraged. The Company will pay the retainer in quarterly installments of $2,500. Any non-employee Chairman of the Board will receive an annual retainer of $20,000 per year.

     B.  Meeting Fee . Non-employee directors (other than the Chairman of the Board) will receive a $2,000 meeting fee for attendance at each meeting of the Board. The Chairman of the Board will receive a $4,000 meeting fee for attendance at each meeting of the Board. Directors will receive meetings fees for attendance in person or, where necessary, by telephone. However, no meeting fees will be paid for participation in meetings of the Board which are held entirely by telephone, except as otherwise agreed by the Board. The Company will pay meeting fees promptly following each meeting.

 


 

     C.  Committee Service . The Chairman of the Audit Committee will receive an annual retainer of $5,000 per year. The Chairman of the Compensation Committee and the Chairman of the Governance and Nominating will each receive an annual retainer of $3,000 per year. The Company will pay the annual retainers in quarterly installments. There will be additional compensation for service on committees of the Board which will consist of stock option awards as specified below in Section IV(C).

IV. Stock Option Awards

     A.  Initial Grants . Non-employee directors will receive a stock option grant of 25,000 shares of common stock upon their initial election or appointment to the Board. The exercise price will be the closing price of the common stock on the date of their appointment or election, as applicable. These options will vest in four equal annual installments with the first 25% vesting on the twelve month anniversary of the date of grant.

     B.  Annual Service Grants . Non-employee directors (other than the Chairman of the Board) who have served for at least six months will receive an annual stock option grant of 15,000 shares of common stock on the date of each annual meeting of stockholders at which they are re-elected. The Chairman of the Board will receive an annual stock option grant of 20,000 shares of common stock on the same terms. The exercise price for the annual option grants will be the closing price of the common stock on the date of the annual stockholder meeting.

     C.  Committee Service Grants . Non-employee directors (other than the committee chairman) will receive a stock option grant of 2,000 shares of common stock for attendance at each committee meeting. The chairman of the committee will receive a stock option grant of 4,000 shares of common stock for attendance at each committee meeting. Committee members may attend meetings in person or, where necessary, by telephone, and committee service grants will apply to telephonic committee meetings. The exercise price for the committee service grants will be the closing price of the common stock on the date of the applicable committee meeting.

     D.  Grant Date, Duration and Vesting . Unless otherwise specified in this policy, all stock options awarded to non-employee directors under this policy will (1) be non-qualified stock options, (2) have an effective grant date that is the same as the date used to determine the exercise price, (3) have a duration of ten years from the date of grant, and (4) vest in two equal annual installments with the first 50% vesting on the twelve month anniversary of the date of grant.

V. Expense Reimbursement

     Non-employee directors are entitled to reimbursement for all reasonable and customary out of pocket and travel expenses incurred in the normal course of Company business.

2


 

VI. Administration and Interpretation

     The Board will have complete discretion to resolve any questions relating to the administration or interpretation of this policy, and their decision will be final and binding on all non-employee directors. Unless otherwise required by the context, all references in this policy to a “ year ” refer to the year between annual stockholder meetings.

VII. Amendments

     The Board has adopted this policy based on the business and economic conditions in existence at the time of adoption and intends to periodically review the policy in light of changes in those conditions. Therefore, the Board reserves the right to amend this policy at any time and in any manner that it deems necessary, appropriate or desirable to reflect the best interests of the Company. The Board also reserves the right to vary from the policy from time to time without amending it and shall do so by resolution of the Board.

*** [END OF DOCUMENT] ***

3

 

Exhibit 10.4

IRELL & MANELLA LLP
David Siegel (101355)
dsiegel@irell.com
Daniel P. Lefler (151253)
dlefler@irell.com
Richard H. Zelichov (193858)
rzelichov@irell.com
Pamela K. Graham (216309)
pgraham@irell.com
1800 Avenue of the Stars, Suite 900
Los Angeles, California 90067-4276
Telephone: (310) 277-1010
Facsimile: (310) 203-7199

Attorneys for Defendants
SUPERCONDUCTOR TECHNOLOGIES INC.,
M. PETER THOMAS, and MARTIN S. McDERMUT

[additional counsel on signature page]

UNITED STATES DISTRICT COURT

CENTRAL DISTRICT OF CALIFORNIA

WESTERN DIVISION

                         
 
                   
    )                  
MARC A. BACKHAUS, on Behalf of     )         Case No. CV-04-2680 DT (JTLx)
Himself and All Others Similarly Situated,     )         Consolidated with
      )         CV-04-02848 DT and CV-04-02927 DT
     Plaintiff,
    )                  
      )         STIPULATION OF SETTLEMENT
v.
    )                  
      )         CLASS ACTION — PSLRA
SUPERCONDUCTOR
    )                  
TECHNOLOGIES INC.,
    )                  
M. PETER THOMAS, and
    )                  
MARTIN S. MCDERMUT,
    )                  
 
    )                  
      Defendants.
    )                  
 
)                  
    )         PLACE:   255 East Temple Street
This Document Relates To:
    )         COURTROOM:   880  
    )                  
ALL ACTIONS     )         Honorable Dickran Tevrizian
    )                  
 
)                  

 


 

STIPULATION OF SETTLEMENT

     This Stipulation of Settlement (the “Stipulation”), dated as of March 8, 2005, is made and entered into by and among the following parties (as defined further in Section V herein) to the above-entitled action: (i) Lead Plaintiffs (as defined below), on behalf of themselves and each of the Settlement Class Members (as defined below), by and through their counsel of record in the action; and (ii) the Defendants (as defined below), by and through their counsel of record in the Class Action (collectively the “Settling Parties”). The Stipulation is intended by the Settling Parties to fully, finally and forever resolve, discharge and settle the Released Claims (as defined below), upon and subject to the terms and conditions hereof.

I. THE CLASS ACTION

     A.  The Class Actions

     On and after April 16, 2004, three federal securities class action complaints, including Marc A. Backhaus v. Superconductor Technologies Inc., et al. , Case No. CV04-2680 DT (JTLx), were filed against Superconductor Technologies Inc. (“STI”), M. Peter Thomas, and Martin S. McDermut in the Central District of California. By an order of the Honorable Dickran Tevrizian dated on or about August 2, 2004, these complaints were consolidated under the caption Backhaus v. Superconductor Technologies Inc., et al. , Case No. CV04-2680 DT (JTLx) (the “Class Action”). In the same order, the Court appointed Marc A. Backhaus and Jay Jakubowitz as lead plaintiffs (“Lead Plaintiffs”) and appointed Federman & Sherwood as lead counsel (“Lead Plaintiffs’ Counsel”).

     On October 4, 2004 after conducting further review of STI’s press releases and public filings and after hiring a private investigator to interview certain of STI’s former employees, Lead Plaintiffs’ Counsel filed a First Amended Consolidated Class Action Complaint (the “First Amended Complaint”). The First Amended Complaint asserted claims against STI and the Individual Defendants for alleged violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The First Amended Complaint sought recovery for purchasers of common stock during the

- 1 -


 

period from January 9, 2004 through March 1, 2004, inclusive. The First Amended Complaint alleged that during the Settlement Class Period (as defined below), STI issued false and misleading statements that materially inflated STI’s stock price. Lead Plaintiffs claimed primarily that STI issued false and misleading projections of its first quarter total net revenues.

II. PRE-TRIAL PROCEEDINGS, INVESTIGATION, AND DISCOVERY

     A.  Investigation and Research Conducted by Plaintiffs

     Lead Plaintiffs’ Counsel has conducted an investigation during the prosecution of the Class Action. This investigation has included, inter alia , (i) consultations with experts; (ii) review of STI’s public filings, annual reports, and other public statements; and (iii) research of the applicable law with respect to the claims asserted in the Class Action and the potential defenses thereto. In addition, by order dated December 1, 2004, the Court granted in part a motion filed by Lead Plaintiffs’ Counsel to limit the scope of certain confidentiality agreements signed by former STI employees. Pursuant to this order, the parties jointly retained the Honorable Enrique Romero (ret.) to serve as a Special Master to implement the relief prescribed in the Court’s December 1, 2004 order, and questionnaires were sent to 122 of STI’s former employees concerning the allegations of the First Amended Complaint. Lead Plaintiffs’ Counsel has inspected and reviewed the responses of all former employees who returned the questionnaires.

     B.  Pre-Trial Proceedings

     On November 18, 2004, the Defendants filed a Motion to Dismiss the First Amended Complaint, which Lead Plaintiffs opposed by Memorandum dated December 22, 2004. The hearing on the Motion to Dismiss has been taken off calendar in light of the Settlement.

     C.  Discovery

     Defendants have agreed to provide Lead Plaintiffs’ Counsel with certain documents relating to STI’s revenues and projections for the fourth quarter of 2003 and

- 2 -


 

first quarter of 2004 so that Lead Plaintiffs’ Counsel can conduct additional due diligence with respect to the Stipulation of Settlement.

III. SETTLEMENT NEGOTIATIONS AND MEDIATION

     From around December 2004 through February 2005, the parties conducted extensive informal settlement discussions, in which the parties, among other things, presented their respective views regarding the merits of the Class Action and defenses, the evidence, and damages analyses. When the informal discussions did not prove fruitful, the parties opted to continue their discussions through a formal mediation process before the Honorable Daniel Weinstein (ret.), in an effort to settle the Class Action.

     On February 11, 2005, the parties to the Class Action, through their respective counsel and representatives, participated in a mediation session with Judge Weinstein. During this meeting, which took place after Judge Weinstein received briefs from the parties, the parties and Judge Weinstein discussed, among other things, the parties’ respective claims and defenses, expert damages analyses, legal analyses, the discovery and motion practice conducted and expected to be conducted in the Class Action, the evidence expected to be offered by the parties at trial, the Lead Plaintiffs’ ability to meet the heightened pleading standards of the Private Securities Litigation Reform Act of 1995, STI’s financial position, initial evidence and other important factual and legal issues and matters relating to the merits of the Class Action. At the conclusion of the mediation, Judge Weinstein orally recommended that the parties approve the settlement discussed and negotiated during the mediation.

IV. CLAIMS OF LEAD PLAINTIFFS AND BENEFITS OF SETTLEMENT

     Lead Plaintiffs believe that the claims asserted in the Class Action have merit and that the evidence developed to date in the Class Action supports the claims asserted. Lead Plaintiffs assert, and believe they would present supporting evidence at trial, that Defendants caused the price of STI common stock to be artificially inflated during the Settlement Class Period by the issuance of materially false statements and by omitting to

- 3 -


 

state material information concerning STI and that as a result Lead Plaintiffs and Settlement Class Members were injured.

     Lead Plaintiffs’ Counsel recognize and acknowledge the expense and length of continued proceedings necessary to prosecute the Class Action through trial and through appeals. Lead Plaintiffs’ Counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex actions such as the Class Action, as well as the difficulties and delays inherent in such litigation. Lead Plaintiffs’ Counsel also are mindful of the inherent problems of proof under and possible defenses to the violations asserted in the Class Action, including the defenses asserted by Defendants during the Class Action, in motions on the pleadings, settlement negotiations and in the mediation proceedings. In addition, Lead Plaintiffs’ Counsel investigated STI’s financial position and has noted that STI has limited financial resources to pay any judgment even if Lead Plaintiffs succeeded in the Class Action. Lead Plaintiffs’ Counsel also recognized that any substantial judgment in the Class Action might result in STI’s bankruptcy which could leave Lead Plaintiffs and the Settlement Class with no possibility of recovery. Moreover, Lead Plaintiffs’ Counsel has reviewed the terms of STI’s insurance coverage and noted that the policy is reduced by defense costs incurred in defending the Class Action.

     In light of the foregoing, Lead Plaintiffs’ Counsel agree with Lead Plaintiffs and believe that the settlement set forth in the Stipulation confers substantial benefits upon the Settlement Class (as defined below) and Settlement Class Members. Based on their evaluation, Lead Plaintiffs’ Counsel have determined that the settlement set forth in the Stipulation is in the best interests of the Lead Plaintiffs and the Settlement Class.

V. DEFENDANTS’ STATEMENT AND DENIALS OF WRONGDOING AND LIABILITY

     The Defendants have denied and continue to deny each and all of the claims and contentions alleged by Lead Plaintiffs on behalf of the Settlement Class. The Defendants also have denied and continue to deny, inter alia , the allegations that the prices of STI stock were artificially inflated by reasons of alleged misrepresentations, non-disclosures or

- 4 -


 

otherwise, or that Lead Plaintiffs or the Settlement Class were harmed by the conduct alleged in the Class Action. Defendants believe that throughout the Settlement Class Period they fully and adequately disclosed all material facts regarding STI and made no misrepresentations of material facts regarding STI.

     Nonetheless, the Defendants have concluded that further conduct of the Class Action would be protracted and expensive, and that it is desirable that the Class Action be fully and finally settled in the manner and upon the terms and conditions set forth in this Stipulation in order to limit further expense, inconvenience and distraction, to dispose of the burden of protracted litigation, and to permit the operation of the Company’s business without further distraction and diversion of the Company’s executive personnel with respect to matters at issue in the Class Action. The Defendants also have taken into account the uncertainty and risks inherent in any litigation, especially in complex cases like this Class Action.

     The Defendants have, therefore, determined that it is desirable and beneficial to them that the Class Action be settled in the manner and upon the terms and conditions set forth in this Stipulation. The Defendants enter into this Stipulation and Settlement without in any way acknowledging any fault, liability, or wrongdoing of any kind. There has been no adverse determination by any court or otherwise against any of the Defendants on the merits of the claims asserted by Lead Plaintiffs. Neither this Stipulation, nor any of its terms or provisions, nor any of the negotiations or proceedings connected with it, shall be construed as an admission or concession by any of the Defendants of the merit or truth of any of the allegations or wrongdoing of any kind on the part of any of the Defendants. The Defendants enter into this Stipulation and Settlement based upon, among other things, the parties’ agreement herein that, to the fullest extent permitted by law, neither this Stipulation nor any of its terms or provisions, nor any of the negotiations or proceedings connected therewith, shall be offered as evidence in the Class Action or in any pending or future civil, criminal, or administrative action or other proceeding to establish any liability or admission by any of the Defendants or any of their respective Related Entities or any other

- 5 -


 

matter adverse to any of the Defendants or any of their respective Related Entities, except as expressly set forth herein.

VI. TERMS OF STIPULATION AND AGREEMENT OF SETTLEMENT

     NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED by and among Lead Plaintiffs (for themselves and the Settlement Class Members), and the Defendants, by and through their respective counsel of record, that, subject to the approval of the Court, the Class Action and the Released Claims shall be finally and fully compromised, settled and released, and the Class Action shall be dismissed with prejudice, upon and subject to the terms and conditions of the Stipulation, as follows:

  1.   Definitions

     As used in the Stipulation the following terms have the meanings specified below:

          1.1 “Authorized Claimant” means any Settlement Class Member whose claim for recovery has been allowed pursuant to the terms of the Stipulation.

          1.2 “Claimant” means any Settlement Class Member who files a Proof of Claim in such form and manner, and within such time, as the Court shall prescribe.

          1.3 “Claims Administrator” means RSM McGladrey, Inc., 512 Township Line Road, One Valley Square, Suite 250, Blue Bell, PA 19422.

          1.4 “Company” or “STI” means defendant Superconductor Technologies Inc., a Delaware corporation, and all of its predecessors, successors, present and former parents, subsidiaries, divisions and related or affiliated entities.

          1.5 “Defendants” means STI, M. Peter Thomas, and Martin S. McDermut.

          1.6 “Defendants’ Insurer” means National Union Fire Insurance Company of Pittsburgh, Pa.

          1.7 “Effective Date” means the first date by which all of the events and conditions specified in Section V, ¶ 9.1(a)-(e) of the Stipulation have been met and have occurred.

          1.8 “Escrow Agent” means Federman & Sherwood.

- 6 -


 

          1.9 “Final” means: (i) The date of final affirmance on an appeal from the Judgment, the expiration of the time for a petition for a writ of certiorari to review the Judgment and, if certiorari be granted, the date of final affirmance of the Judgment following review pursuant to that grant; or (ii) the date of final dismissal of any appeal from the Judgment or the final dismissal of any proceeding on certiorari to review the Judgment; or (iii) if no appeal is filed, the expiration date of the time for the filing or noticing of any appeal from the Court’s judgment approving the Stipulation substantially in the form and content of Exhibit “B” hereto, i.e. , thirty-five (35) days after entry of the Judgment (or, if the date for taking an appeal or seeking review shall be extended beyond this time by order of the Court, by operation of law or otherwise, or if such extension is requested, the date of expiration of any extension if any appeal or review is not sought). Any proceeding or order, or any appeal or petition for a writ of certiorari pertaining solely to any plan of allocation and/or application for attorneys’ fees, costs or expenses, shall not in any way delay or preclude the Judgment from becoming Final.

          1.10 “Individual Defendants” means M. Peter Thomas and Martin S. McDermut.

          1.11 “Judgment” means the judgment to be rendered by the Court dismissing the Class Action with prejudice, substantially in the form and content attached hereto as Exhibit “B.”

          1.12 “Parties” means, collectively, each of the Defendants and Lead Plaintiffs on behalf of themselves and the members of the Settlement Class.

          1.13 “Person” means an individual, corporation (including all divisions and subsidiaries), partnership, limited partnership, association, joint stock company, estate, legal representative, trust, unincorporated association, government or any political subdivision or agency thereof, and any business or legal entity and their spouses, heirs, predecessors, successors, representatives, or assigns.

          1.14 “Lead Plaintiffs” means Marc A. Backhaus and Jay Jakubowitz.

- 7 -


 

          1.15 “Lead Plaintiffs’ Counsel” means: Federman & Sherwood, 120 North Robinson Avenue, Suite 2720, Oklahoma City, Oklahoma 73102, telephone (405) 235-1560, facsimile (405) 239-2112.

          1.16 “Notice and Administration Fund” means the principal amount of $50,000.00 deposited by STI in a fund to be managed by the Claims Administrator to be used solely for costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any.

          1.17 “Plan of Allocation” means a plan or formula of allocation of the Settlement Fund to be prepared by Lead Plaintiffs’ Counsel which shall be described in the “Notice of Pendency and Proposed Settlement of Class Action” to be sent to Settlement Class Members in connection with the settlement whereby the Settlement Fund shall be distributed to Authorized Claimants after payment of expenses of notice and administration of the settlement, any taxes, penalties or interest or tax preparation fees owed by the Settlement Fund, and such attorneys’ fees, costs, expenses and interest as may be awarded by the Court. Any Plan of Allocation is not part of the Stipulation.

          1.18 “Related Parties” means each of a Defendant’s past or present directors, officers, employees, partners, principals, agents, underwriters, insurers, co-insurers, reinsurers, controlling shareholders, any entity in which the Defendant and/or any member(s) of any Defendant’s immediate family has or have a controlling interest, attorneys, accountants, auditors, banks, investment banks or investment bankers, advisors, analysts, personal or legal representatives, insurers, reinsurers, predecessors, successors, parents, subsidiaries, divisions, joint ventures, assigns, spouses, heirs, associates, related or affiliated entities, any members of their immediate families, or any trust of which any Defendant is the trustee or settlor or which is for the benefit of any Defendant and/or member(s) of his family. Any retail securities broker retained by a Settlement Class

- 8 -


 

Member (and not retained by STI) that specifically recommended STI stock on the secondary market to a Settlement Class Member is excluded from the definition of “Related Parties.”

          1.19 “Released Claims” shall collectively mean all claims (including “Unknown Claims” as defined in ¶ 1.27 hereof), demands, rights, liabilities and causes of action of every nature and description whatsoever, known or unknown, whether in contract, tort, equity or otherwise, whether or not concealed or hidden, asserted or that might have been asserted in this or any other forum or proceeding, including, without limitation, claims for negligence, gross negligence, indemnification, breach of duty of care and/or breach of duty of loyalty, fraud, misrepresentation, breach of fiduciary duty, negligent misrepresentation, unfair competition, insider trading, professional negligence, mismanagement, corporate waste, breach of contract, or violations of any state or federal statutes, rules or regulations, by or on behalf of Lead Plaintiffs, the Settlement Class, or any Settlement Class Member against the Released Persons (as defined below) which are based upon or related to the purchase or acquisition of STI common stock by any Settlement Class Member during the Settlement Class Period and the facts, transactions, events, occurrences, acts, disclosures, statements, omissions or failures to act which were or could have been alleged in the Class Action, or any other forum.

          1.20 “Released Persons” means each and all of the Defendants and their respective Related Parties.

          1.21 “Representative Plaintiffs” means each of the plaintiffs who filed a complaint in the Class Action, including, but not limited to the Lead Plaintiffs.

          1.22 “Representative Plaintiffs’ Counsel” means each counsel who has appeared as counsel for any of the Representative Plaintiffs in the Class Action, including, but not limited to Lead Plaintiffs’ Counsel.

          1.23 “Settlement Class” means all Persons (except Defendants, members of the immediate family of any Defendant, any entity in which any Defendant has a controlling interest, and the legal representatives, heirs, successors or assigns of any such

- 9 -


 

excluded party) who purchased or otherwise acquired STI common stock during the period from January 9, 2004 through March 1, 2004, inclusive, excluding those persons who timely and validly request exclusion from the Settlement Class.

          1.24 “Settlement Class Member” or “Member of the Settlement Class” means a Person who falls within the definition of the Settlement Class as set forth in ¶ 1.23, above.

          1.25 “Settlement Class Period” means the period from January 9, 2004 through March 1, 2004, inclusive.

          1.26 “Settlement Fund” means the principal amount of Four Million Dollars ($4,000,000) in cash, for and on behalf of the Defendants, less the cost of notice, plus interest earned or accrued thereon.

          1.27 “Unknown Claims” means any Released Claims which the Lead Plaintiffs or any Settlement Class Member does not know or suspect to exist in his, her or its favor at the time of the release of the Released Persons which, if known by him, her or it, might have affected his, her or its settlement with and release of the Released Persons, or might have affected his, her or its decision not to object to, or opt out of, this settlement. With respect to any and all Released Claims, the Parties stipulate and agree that, upon the Effective Date, the Lead Plaintiffs expressly waive and relinquish, and the Settlement Class Members shall be deemed to have, and by operation of the Judgment shall have expressly waived and relinquished, to the fullest extent permitted by law, the provisions, rights, and benefits of § 1542 of the California Civil Code, which provides:

A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.

The Lead Plaintiffs expressly waive and the Settlement Class Members shall be deemed to, and upon the Effective Date and by operation of the Judgment shall, have waived any and all provisions, rights and benefits conferred by any law of the United States or of any state or territory of the United States, or principle of common law, which is similar, comparable or equivalent to § 1542 of the California Civil Code. The Lead Plaintiffs and the

- 10 -


 

Settlement Class Members may hereafter discover facts in addition to or different from those which he, she or it now knows or believes to be true with respect to the subject matter of the Released Claims, but each of them hereby stipulate and agree that the Lead Plaintiffs do settle and release, and each Settlement Class Member shall be deemed to, upon the Effective Date and by operation of the Judgment shall have, fully, finally, and forever settled and released any and all Released Claims, known or unknown, suspected or unsuspected, contingent or non-contingent, whether or not concealed or hidden, which now exist, or heretofore have existed upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to, conduct which is negligent, intentional, with or without malice, or a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional facts. The Parties acknowledge that the foregoing waiver was bargained for and a key element of the Settlement of which this release is a part.

               2.  The Settlement Funds .

          2.1 Defendants shall cause the Settlement Fund to be transferred to the Escrow Agent as follows: (a) by April 12, 2005 or (b) within ten (10) business days after preliminary approval of this Stipulation as provided in ¶ 5.1 below, whichever is later (the “Funding Date”), Defendants’ Insurer shall wire transfer $4,000,000 to the Escrow Agent.

          2.2 STI shall cause the Notice and Administration Fund to be transferred to the Claims Administrator within five (5) business days after preliminary approval of this Stipulation as provided in ¶ 5.1 below.

               3.  Certification of the Settlement Class .

          3.1 For the sole purpose of implementation, approval and consummation of the Settlement, the Settling Parties stipulate and agree that the Court may enter an order certifying the Settlement Class, appointing the Lead Plaintiffs as the representatives of the Settlement Class, and appoint Lead Plaintiffs’ Counsel as counsel for the Settlement Class.

          3.2 Certification of the Settlement Class and appointment of Lead Counsel as counsel for the Settlement Class, as set forth herein, shall be binding only with respect

- 11 -


 

to the Settlement set forth in the Stipulation. In the event that this Stipulation is terminated or cancelled or that the Effective Date does not occur for any reason, the stipulated certification of the Settlement Class shall be vacated and the Class Action shall proceed as though the Settlement Class had never been certified. Except to effectuate the Settlement, neither the Settling Parties, their respective counsel, nor any member of the Settlement Class shall cite, present as evidence or legal precedent, rely upon, make reference to or otherwise make any use whatsoever of this stipulated certification of the Settlement Class, in this Class Action or in any other proceeding.

  4.   Administration Of The Settlement Fund

                    (a)  The Escrow Agent

          4.1 The Escrow Agent shall invest the Settlement Fund in instruments backed by the full faith and credit of the United States Government or fully insured by the United States Government or an agency thereof and shall reinvest the proceeds of these instruments as they mature in similar instruments at the current market rates.

          4.2 The Escrow Agent shall not disburse the Settlement Fund except as provided in the Stipulation, or by an order of the Court (consistent with the terms of the Stipulation), or with the written agreement of counsel for the Defendants and Lead Plaintiffs’ Counsel.

          4.3 Subject to such further order and direction by the Court as may be necessary, the Escrow Agent is authorized to execute such transactions on behalf of the Settlement Class Members as are consistent with the terms of the Stipulation.

          4.4 All funds held by the Escrow Agent shall be deemed and considered to be in custodia legis of the Court, and shall remain subject to the jurisdiction of the Court, until such time as such funds shall be distributed pursuant to the Stipulation and/or further order(s) of the Court consistent with the terms of the Stipulation.

          4.5 Within five (5) days after preliminary approval of this Stipulation as provided in ¶ 5.1 below, STI shall cause the Notice and Administration Fund to be sent to the Claims Administrator to be used solely for costs and expenses reasonably and actually

- 12 -


 

incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any. The Claims Administrator shall have the right to use the funds in the Notice and Administration Fund to pay the first $50,000.00 in costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any, provided that the Claims Administrator sends copies of receipts for all such costs and expenses to counsel for STI.

          4.6 Neither Defendants nor their counsel shall have any further responsibility for the costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any, above the Notice and Administration Fund. Any costs and expenses reasonably and actually incurred in connection with providing notice to the Settlement Class, locating Settlement Class Members, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to Members of the Settlement Class, processing Proofs of Claim and Releases, and paying escrow fees and costs, if any, above the Notice and Administration Fund shall be paid from the Settlement Fund.

          4.7 On the Effective Date, any balance (including interest) then remaining in the Notice and Administration Fund, less expenses incurred but not yet paid, must be transferred by the Claims Administrator to STI.

- 13 -


 

          4.8 All costs and expenses associated with the Settlement, the Settlement Fund, including but not limited to any taxes, administrative costs, and costs of providing notice of the proposed Settlement to the Settlement Class, over and above the $50,000.00 available in the Notice and Administration Fund, shall be paid from the Settlement Fund, and in no event shall any of the Defendants, Lead Plaintiffs, Settlement Class Members, or their counsel bear any responsibility for any such costs or expenses.

               (b)  Taxes

          4.9 (a) The Parties and the Escrow Agent agree to treat the Settlement Fund as being at all times a “qualified settlement fund” within the meaning of Treas. Reg. Section 1.468B-1. In addition, the Escrow Agent and, as required, the Defendants and the Defendants’ insurer contributing any settlement consideration shall jointly and timely make the “relation-back election” (as defined in Treas. Reg. Section 1.468B-1) back to the earliest permitted date. Such election shall be made in compliance with the procedures and requirements contained in such regulations. It shall be the responsibility of the Escrow Agent to timely and properly prepare, and deliver the necessary documentation for signature by all necessary parties, and thereafter to cause the appropriate filing to occur.

               (b) For the purposes of Section 468B of the Internal Revenue Code of 1986, and Treas. Reg. Section 1.468B, the “administrator” shall be the Escrow Agent. The Escrow Agent shall timely and properly file all informational and other tax returns necessary or advisable with respect to the Settlement Fund (including, without limitation, the returns described in Treas. Reg. Section 1.468B-2(l)). Such returns (as well as the election described in ¶ 4.9(a)) shall be consistent with this ¶ 4.9 and in all events shall reflect that all taxes (including any estimated taxes, interest or penalties) on the income earned by the Settlement Fund shall be paid out of the Settlement Fund as provided in ¶ 4.9(c) hereof.

               (c) All (i) taxes (including any estimated taxes, interest or penalties) arising with respect to the income earned by the Settlement Fund (“Taxes”), and (ii) expenses and costs incurred in connection with the operation and implementation of

- 14 -


 

this ¶ 4.9 (including, without limitation, expenses of tax attorneys and/or accountants and mailing and distribution costs and expenses relating to filing (or failing to file) the returns described in this ¶ 4.9) (“Tax Expenses”), shall be paid out of the Settlement Fund; in all events the Released Persons shall not have any liability or responsibility for the Taxes, the Tax Expenses, or the filing of any tax returns or other documents with the Internal Revenue Service or any other state or local taxing authority. The Escrow Agent shall indemnify and hold the Released Persons harmless for Taxes and Tax Expenses (including, without limitation, Taxes payable by reason of any such indemnification). Further, Taxes and Tax Expenses shall be treated as, and considered to be, a cost of administration of the Settlement and shall be timely paid by the Escrow Agent out of the Settlement Fund without prior order from the Court, and the Escrow Agent shall be obligated (notwithstanding anything herein to the contrary) to withhold from distribution to Authorized Claimants any funds necessary to pay such amounts (as well as any amounts that may be required to be withheld under Treas. Reg. Section 1.468B-2(1)(2)); the Released Persons are not responsible and shall have no liability therefor, or for any reporting requirements that may relate thereto. The Parties hereto agree to cooperate with the Escrow Agent, each other, and their tax attorneys and accountants to the extent reasonably necessary to carry out the provisions of this ¶ 4.9.

                    c.  Termination

          4.10 In the event that the Stipulation is not approved, or is terminated, canceled, or fails to become effective for any reason, the Settlement Fund (including accrued interest), less the costs of notice to the Settlement Class incurred pursuant to ¶ 4.8 herein, and less any Taxes or Tax Expenses paid or incurred pursuant to ¶ 4.9 herein shall be refunded to the Defendants’ Insurer.

          4.11 In the event that the Stipulation is not approved, or is terminated, canceled, or fails to become effective for any reason, the Notice and Administration Fund (including accrued interest) less the costs of notice to the Settlement Class incurred pursuant to ¶ 4.5 herein, shall be refunded to STI.

- 15 -


 

  5.   Notice Order And Settlement Hearing

          5.1 Promptly after execution of the Stipulation, but in no event later than ten (10) days after the Stipulation is signed (unless such time is extended by the written agreement of Lead Plaintiffs’ Counsel and counsel for the Defendants), the Parties shall submit the Stipulation together with its Exhibits to the Court and shall jointly apply for entry of an order (the “Notice Order”), substantially in the form and content of Exhibit “A” hereto, requesting that the Settlement Class be certified, the preliminary approval of the settlement set forth in the Stipulation, and approval for the mailing and publication of a Notice of Pendency and Proposed Settlement of Class Action which shall include the general terms of the settlement set forth in the Stipulation, the proposed Plan of Allocation, the general terms of the Fee and Expense Application (as defined in ¶ 8.1) and the date of the Settlement Hearing (as defined below in ¶ 5.2).

          5.2 The Parties shall request that, after notice is given, the Court hold a Hearing (the “Settlement Hearing”) and finally approve this settlement as set forth herein. At or after the Settlement Hearing, Lead Plaintiffs’ Counsel also will request that the Court approve the proposed Plan of Allocation and the Fee and Expense Application.

  6.   Releases

          6.1 Upon the Effective Date, the Representative Plaintiffs shall release, relinquish and discharge, and each of the Settlement Class Members shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished and discharged all Released Claims (including “Unknown Claims”) against each and all of the Released Persons, whether or not such Settlement Class Member executes and delivers the Proof of Claim and Release.

          6.2 Upon the Effective Date, each of the Defendants shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished and discharged the Representative Plaintiffs, the Settlement Class Members, and Representative Plaintiffs’ Counsel from all claims (including “Unknown Claims”),

- 16 -


 

arising out of, relating to, or in connection with the institution, prosecution, assertion or resolution of the Class Action or the Released Claims.

          6.3 Upon the Effective Date, the Representative Plaintiffs, the Settlement Class Members, and Representative Plaintiffs’ Counsel shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished and discharged the Released Persons from all claims (including “Unknown Claims”), arising out of, relating to, or in connection with the defense, or resolution of the Class Action or the Released Claims.

          6.4 Except as otherwise expressly provided for in this Stipulation, the Settling Parties shall each bear their own respective attorneys’ fees, expenses and costs incurred in connection with the conduct and settlement of the Class Action, and the preparation, implementation and performance of the terms of this Stipulation.

          6.5 Only those Settlement Class Members filing valid and timely Proofs of Claim and Release shall be entitled to participate in the settlement and receive any distributions from the Settlement Fund. The Proofs of Claim and Release to be executed by the Settlement Class Members shall release all Released Claims against the Released Persons, and shall be substantially in the form and content of Exhibit “A-3” hereto. All Settlement Class Members shall be bound by the releases set forth therein whether or not they submit a valid and timely Proof of Claim and Release.

  7.   Administration And Calculation Of Claims, Final Awards And Supervision And Distribution Of Settlement Fund

          7.1 Lead Plaintiffs’ Counsel, or its authorized agents, acting on behalf of the Settlement Class, and subject to the supervision, direction and approval of the Court, shall administer and calculate the claims submitted by Settlement Class Members and shall oversee distribution of that portion of the Settlement Fund that is finally awarded by the Court to Authorized Claimants.

          7.2 The Settlement Fund shall be applied as follows:

- 17 -


 

               (a) To pay all unpaid costs and expenses, above the $50,000.00 in the Notice and Administration Fund, reasonably and actually incurred in connection with providing notice to the Settlement Class Members and to current shareholders of STI including, locating Settlement Class Members and current shareholders of STI, soliciting Settlement Class claims, assisting with the filing of claims, administering and distributing the Settlement Fund to the Settlement Class, processing Proofs of Claim and Release and paying escrow fees and costs, if any;

               (b) To pay Taxes and Tax Expenses;

               (c) To pay Representative Plaintiffs’ Counsel’s attorneys’ fees, expenses and costs, with interest thereon (the “Fee and Expense Award”), if and to the extent allowed by the Court; and

               (d) To distribute the balance of the Settlement Fund (the “Net Settlement Fund”) to Authorized Claimants as allowed by the Stipulation, the Plan of Allocation or the Court.

          7.3 After the Effective Date and subject to such further approval and further order(s) of the Court as may be required, the Net Settlement Fund shall be distributed to Authorized Claimants, subject to and in accordance with the following:

               (a) Within sixty (60) days after the mailing of the Notice or such other time as may be set by the Court, each Person claiming to be an Authorized Claimant shall be required to submit to the Claims Administrator a separate completed Proof of Claim and Release as attached to the Notice and substantially in the form and content of Exhibit “A-3” hereto, signed under penalty of perjury and supported by such documents as specified in the Proof of Claim and Release and as are reasonably available to the Authorized Claimant.

               (b) Except as otherwise ordered by the Court, all Settlement Class Members who fail to timely submit a valid Proof of Claim and Release within such period, or such other period as may be ordered by the Court, or who have not already done so, shall be forever barred from receiving any payments of money or stock pursuant to the

- 18 -


 

Stipulation and the settlement set forth herein, but will in all other respects be subject to and bound by the provisions of the Stipulation, the settlement and releases contained herein, and the Judgment.

               (c) The Net Settlement Fund shall be distributed to the Authorized Claimants in accordance with and subject to the Plan of Allocation to be described in the Notice mailed to Settlement Class Members. The proposed Plan of Allocation shall not be a part of the Stipulation.

          7.4 The Released Persons or their counsel shall have no responsibility for, interest in, or liability whatsoever with respect to: (a) the investment or distribution of the Settlement Fund; (b) the Plan of Allocation; (c) the determination or administration of taxes; or (d) any losses incurred in connection with (a), (b) or (c). No Person shall have any claim of any kind against the Released Persons or their counsel with respect to the matters set forth in this paragraph 7 or any of its subparagraphs.

          7.5 No Person shall have any claim against the Representative Plaintiffs or their counsel (including Lead Plaintiffs’ Counsel), or any claims administrator, or other agent designated by Lead Plaintiffs’ Counsel based on the distributions made substantially in accordance with the Stipulation and the settlement contained herein, the Plan of Allocation or further orders of the Court.

          7.6 The Released Persons or their counsel shall have no responsibility for, interest in, or liability whatsoever with respect to the investment or distribution of the Settlement Fund, the Net Settlement Fund, the Plan of Allocation, the determination, administration, calculation or payment of claims, the payment or withholding of taxes, or any losses or liabilities incurred in connection therewith.

          7.7 It is understood and agreed by the Settling Parties that any proposed Plan of Allocation of the Net Settlement Fund, including, without limitation, any adjustments to an Authorized Claimant’s claim set forth therein, is not a material part of the Stipulation and is to be considered by the Court separately from the Court’s consideration of the fairness, reasonableness and adequacy of the settlement set forth in the Stipulation,

- 19 -


 

and any order or proceedings relating to the Plan of Allocation shall not operate to terminate or cancel the Stipulation or affect the finality of the Court’s Judgment approving the Stipulation and the settlement set forth herein, including, but not limited to, the release, discharge, and relinquishment of the Released Claims against the Released Persons, or any other orders entered pursuant to the Stipulation.

  8.   Representative Plaintiffs’ Counsel’s Attorneys’ Fees And Reimbursement Of Expenses

          8.1 The Representative Plaintiffs’ or their counsel may submit an application or applications for an order (the “Fee and Expense Application”) for distributions to them from the Settlement Fund for: (i) an award of attorneys’ fees up to 30% of the Settlement Fund plus (ii) reimbursement of all expenses and costs, including the fees of any experts or consultants, incurred in connection with prosecuting the Class Action, not to exceed $62,000.00, plus (iii) interest on such attorneys’ fees, costs and expenses at the same rate and for the same periods as earned by the Settlement Fund (until paid), as may be awarded by the Court.

          8.2 The attorneys’ fees, expenses and costs, including the fees of experts and consultants, as awarded by the Court (the “Fee and Expense Award”), shall be transferred to Lead Plaintiffs’ Counsel from the Settlement Fund, within five (5) business days after the Court enters the Judgment or five (5) business days after the Court approves the Fee and Expense Award, whichever is later. Lead Plaintiffs’ Counsel shall thereafter allocate the Fee and Expense Award among Representative Plaintiffs’ Counsel in a manner in which Lead Plaintiffs’ Counsel in good faith believe reflects the contributions of such counsel to the prosecution and settlement of the Class Action; provided, however, that in the event that the Judgment or the Order making the Fee and Expense Award is reversed or modified on appeal, and in the event that the Fee and Expense Award has been paid to any extent, then Representative Plaintiffs’ Counsel shall within ten (10) business days from any such reversal or modification, refund to the Settlement Fund the fees, expenses, costs and interest previously paid to them from the Settlement Fund, including accrued interest on

- 20 -


 

any such amount at the average rate earned on the Settlement Fund from the time of withdrawal until the date of refund. Each such Representative Plaintiffs’ Counsel’s law firm, as a condition of receiving any portion of such fees and expenses, on behalf of itself and each partner and/or shareholder of it, agrees that the law firm and each of its partners and/or shareholders are subject to the jurisdiction of the Court for the purpose of enforcing this ¶ 8.2 of the Stipulation. Each such Representative Plaintiffs’ Counsel’s law firm, as a condition of receiving any portion of such fees and expenses, on behalf of itself and each partner and/or shareholder of it, agrees that the law firm and each of its partners and/or shareholders shall be jointly and severally liable with each other Representative Plaintiffs’ Counsel’s law firm that received any part of the Fee and Expense Award for any refund to the Settlement Fund of the fees the fees, expenses, costs and interest previously paid to them from the Settlement Fund, including accrued interest on any such amount at the average rate earned on the Settlement Fund from the time of withdrawal until the date of refund. Without limitation, each such law firm and its partners and/or shareholders agree that the Court may, upon application of Defendants, or Lead Plaintiffs’ Counsel, on notice to counsel to the Representative Plaintiffs, summarily issue orders, including, but not limited to, judgments and attachment orders, and may make appropriate findings of or sanctions for contempt, against them or any of them should such law firm fail timely to repay fees and expenses pursuant to this ¶ 8.2 of the Stipulation.

          8.3 The Released Persons shall have no responsibility for, and no liability whatsoever with respect to, any payment to Lead Plaintiffs’ Counsel or any Representative Plaintiffs’ Counsel from the Settlement Fund that may occur before the Effective Date.

          8.4 The Released Persons shall have no responsibility for, and no liability whatsoever with respect to, the allocation of the Fee and Expense Award among Representative Plaintiffs’ Counsel, or any other Person who may assert some claim thereto, or any Fee and Expense Awards that the Court may make in the Class Action.

          8.5 The procedure for and the allowance or disallowance by the Court of the Fee and Expense Application are not part of the settlement set forth in the Stipulation, and

- 21 -


 

are to be considered by the Court separately from the Court’s consideration of the fairness, reasonableness and adequacy of the settlement set forth in the Stipulation. Any order or proceedings relating to the Fee and Expense Application, or any appeal from any order relating thereto, shall not operate to terminate or cancel the Stipulation, or affect or delay the finality of the Judgment approving the Stipulation and the settlement of the Class Action set forth herein.

  9.   Conditions Of Settlement, Effect Of Disapproval, Cancellation Or Termination

          9.1 The Effective Date of the Stipulation shall be conditioned on the occurrence of all of the following events:

               (a) The Defendants’ Insurer shall have timely transferred or caused to be timely transferred the Settlement Fund to the Escrow Agent as required in ¶ 2, above;

               (b) The Court has entered the Notice Order and certified the Settlement Class, as required by ¶¶ 3.1 and 5.1, above;

               (c) The Court has entered the Judgment, or a judgment substantially in the form and content of Exhibit “B”;

               (d) The Judgment has become Final, as defined in ¶ 1.9, above;

               (e) Counsel for the Defendants has not given notice of intent to exercise the option to terminate the Stipulation and settlement in accordance with the terms of the Supplemental Agreement described in ¶ 9.9.

          9.2 Upon the occurrence of all of the events referenced in ¶ 9.1 above, any and all remaining interest or right of the Defendants and their insurers to the Settlement Fund shall be absolutely and forever extinguished.

          9.3 Neither a modification nor a reversal on appeal of any Plan of Allocation or of any amount of attorneys’ fees, costs, expenses and interest awarded by the Court to any of the Representative Plaintiffs’ Counsel shall constitute a condition to the Effective Date or grounds for cancellation and termination of the Stipulation.

- 22 -


 

          9.4 If any of the conditions specified in ¶ 9.1, above, are not met, then the Stipulation shall be cancelled and terminated unless Lead Plaintiffs’ Counsel and counsel for Defendants mutually agree in writing to proceed with the Stipulation.

          9.5 Unless otherwise ordered by the Court, in the event the Stipulation shall terminate, or be canceled, or shall not become effective for any reason, within five (5) business days after written notification of such event is sent by counsel for Defendants or Lead Plaintiffs’ Counsel to the Escrow Agent, the Settlement Fund (including accrued interest), less expenses and any costs which have been used to provide notice of the proposed Settlement to the Settlement Class, and less any Taxes and Tax Expenses paid or incurred pursuant to ¶ 4.9 herein, shall be refunded by the Escrow Agent to the Defendants’ Insurer. In such event, any tax refund owing to the Settlement Fund shall also be refunded and paid to the Defendants’ Insurer. At the request of the Defendants, the Escrow Agent or its designee shall apply for any such refund and pay the proceeds, less the cost of obtaining the tax refund, to Defendants’ Insurer.

          9.6 Unless otherwise ordered by the Court, in the event the Stipulation shall terminate, or be canceled, or shall not become effective for any reason, within five (5) business days after written notification of such event is sent by counsel for Defendants or Lead Plaintiffs’ Counsel to the Claims Administrator, the Notice and Administration Fund (including accrued interest), less expenses and any costs which have been used to provide notice of the proposed Settlement to the Settlement Class shall be refunded by the Claims Administrator to STI.

          9.7 In the event that the Stipulation is not approved by the Court or the settlement set forth in the Stipulation is terminated or fails to become effective in accordance with its terms, this Stipulation and all negotiations and proceedings relating hereto shall be without prejudice a) to any or all Settling Parties who shall be restored to their respective positions in the Class Action as of February 11, 2005. In such event, the terms and provisions of the Stipulation, with the exception of ¶¶ 1.1-1.27, 3.2, 4.2, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.10, 4.11, 7.4, 7.5, 7.6, 8.2, 8.3, 8.4, 9.1-9.10 herein, shall have no

- 23 -


 

further force and effect with respect to the Settling Parties and shall not be used in the Class Action or in any other proceeding for any purpose and any Judgment or Order entered by the Court in accordance with the terms of the Stipulation shall be treated as vacated, nunc pro tunc . No order of the Court or modification or reversal on appeal of any order of the Court concerning the Plan of Allocation or the amount of any attorneys’ fees, costs, expenses and interest awarded by the Court to the Representative Plaintiffs or any of their counsel shall constitute grounds for cancellation or termination of the Stipulation.

          9.8 If a case is commenced in respect to any Defendant under Title 11 of the United States Code (Bankruptcy), or a trustee, receiver or conservator is appointed under any similar law, and in the event of the entry of a final order of a court of competent jurisdiction determining the transfer of the Settlement Fund, or any portion thereof, by or on behalf of such Defendant to be a preference, voidable transfer, fraudulent conveyance or similar transaction, then, as to such Defendant only, the releases given and Judgment entered in favor of such Defendant pursuant to this Stipulation shall be null and void.

          9.9 If prior to the Settlement Hearing, Persons who otherwise would be members of the Settlement Class have filed with the Court valid and timely requests for exclusion (“Requests for Exclusion”) from the Settlement Class in accordance with the provisions of the Notice Order and the Notice given pursuant thereto, and such Persons in the aggregate purchased a number of shares during the Settlement Class Period in an amount greater than the sum specified in a separate Supplemental Agreement between the Parties (the “Supplemental Agreement”), Defendants shall have the option to terminate this Stipulation in accordance with the procedures set forth in the Supplemental Agreement. The Supplemental Agreement will not be filed with the Court unless and until a dispute among the Parties concerning its interpretation or application arises. Copies of all Requests for Exclusion received, together with copies of all written revocations of Requests for Exclusion, shall be delivered to counsel for Defendants within two (2) days of receipt thereof.

- 24 -


 

          9.10 In the event this Stipulation shall be cancelled as set forth in ¶ 9.7 above, the Settling Parties shall, within two weeks of such cancellation, jointly request a status conference with the Court to be held on the Court’s first available date. At such status conference, the Settling Parties shall ask the Court’s assistance in scheduling continued proceedings in the Class Action as between the Settling Parties. Pending such status conference or the expiration of sixty (60) days from the Settling Parties’ joint request for a status conference, whichever occurs first, none of the Settling Parties shall file or serve any further motions on any of the other Settling Parties in connection with this Class Action nor shall any response be due by any Settling Party to any outstanding pleading or motion by any other Settling Party.

  10.   Miscellaneous Provisions

          10.1 The Parties (a) acknowledge that it is their intent to consummate this Settlement and Stipulation; and (b) agree to cooperate to the extent necessary to effectuate and implement all terms and conditions of the Stipulation and to exercise their best efforts to accomplish the foregoing terms and conditions of the Stipulation.

          10.2 Each Individual Defendant warrants as to himself or itself that, at the time any of the payments provided for herein are made on behalf of himself or itself, he or it is not insolvent and the payment will not render him or it insolvent. This representation is made by each Individual Defendant as to himself or itself and is not made by counsel for the Individual Defendants.

          10.3 The Parties agree that the amount of the Settlement Fund, as well as the other terms of the settlement were negotiated in good faith by the Parties and reflect a settlement that was reached voluntarily after consultation with experienced legal counsel. Neither the Stipulation nor the Settlement contained therein, nor any act performed or document executed pursuant to or in furtherance of the Stipulation or the Settlement: (i) is or may be deemed to be or may be used as an admission of, or evidence of, the validity of any Released Claim, or of any wrongdoing or liability of the Released Persons; or (ii) is or may be deemed to be or may be used as an admission of, or evidence of, any fault or

- 25 -


 

omission of any of the Released Persons in any civil, criminal or administrative proceeding in any court, administrative agency or other tribunal. Released Persons may file the Stipulation and/or the Judgment from this action in any other action that may be brought against them in order to support a defense or counterclaim based on principles of res judicata , collateral estoppel, release, good faith settlement, judgment bar or reduction or any theory of claim preclusion or issue preclusion or similar defense or counterclaim.

          10.4 The Settling Parties intend for this settlement to be a final and complete resolution of all disputes asserted or which could be asserted by the Settlement Class Members against the Released Persons with respect to the Released Claims. Accordingly, the Parties agree not to assert in the Class Action or in any other judicial forum that the Class Action was brought or defended in bad faith or without a reasonable basis. Defendants agree not to assert any claim under Rule 11 of the Federal Rules of Civil Procedure or any similar law, rule or regulation, that the Class Action was brought in bad faith or without a reasonable basis. Lead Plaintiffs and the Settlement Class agree not to assert any claim under Rule 11 of the Federal Rules of Civil Procedure or any similar law, rule or regulation that any pleading filed, motion made or position taken by Defendants, or their counsel, in the Class Action was filed, made or taken in bad faith or without a reasonable basis. The Settling Parties agree that the amount paid and the other terms of the Settlement were negotiated at arm’s length and in good faith by the Settling Parties, and reflect a settlement that was reached voluntarily based upon adequate information and after consultation with experienced legal counsel, and under the supervision of the Mediator.

          10.5 To the extent permitted by law, all agreements made and orders entered during the course of the Class Action relating to the confidentiality of information shall survive this Stipulation.

          10.6 The waiver by one party of any breach of this Stipulation by any other party shall not be deemed a waiver of any other prior or subsequent breach of this Stipulation.

- 26 -


 

          10.7 All of the Exhibits to the Stipulation are material and integral parts hereof and are fully incorporated herein by this reference.

          10.8 In the event that there exists a conflict or inconsistency between the terms of this Stipulation and the terms of any exhibit to be attached hereto, the terms of this Stipulation shall prevail.

          10.9 Nothing in this Stipulation, or the negotiations relating thereto, is intended to or shall be deemed to constitute a waiver of any applicable privilege or immunity, including, without limitation, attorney/client privilege, joint defense privilege, or work product immunity.

          10.10 The Stipulation may be amended or modified only by a written instrument signed by or on behalf of all Parties or their successors-in-interest.

          10.11 The Stipulation, the Exhibits attached hereto and the Supplemental Agreement constitute the entire agreement among the Parties hereto and no representations, warranties or inducements have been made to any party concerning the Stipulation, its Exhibits or the Supplemental Agreement other than the representations, warranties and covenants contained and memorialized in such documents. Except as otherwise provided herein, each party shall bear its own costs.

          10.12 Lead Plaintiffs’ Counsel, on behalf of the Settlement Class, are expressly authorized by the Representative Plaintiffs to take all appropriate action required or permitted to be taken by the Settlement Class pursuant to the Stipulation to effectuate its terms and also are expressly authorized to enter into any modifications or amendments to the Stipulation on behalf of the Settlement Class which they deem appropriate.

          10.13 Each counsel or other Person executing the Stipulation or any of its Exhibits on behalf of any party hereto hereby warrants that such person has the full authority to do so. All orders and agreements entered during the course of the Class Action relative to the confidentiality of information shall survive this Stipulation.

- 27 -


 

          10.14 The Stipulation may be executed by facsimile and in one or more counterparts. All executed counterparts and each of them shall be deemed to be one and the same instrument. Counsel for the Parties to the Stipulation shall exchange among themselves original signed counterparts and a complete set of original executed counterparts shall be filed with the Court.

          10.15 The Stipulation shall be binding upon, and inure to the benefit of, the successors and assigns of the Settling Parties hereto.

          10.16 The Court shall retain jurisdiction with respect to implementation and enforcement of the terms of the Stipulation, and all Parties hereto and their counsel submit to the exclusive jurisdiction of the Court for purposes of implementing and enforcing the settlement embodied in the Stipulation.

          10.17 The Stipulation and the Exhibits hereto shall be considered to have been negotiated, executed and delivered, and to be wholly performed, in the State of California, and the rights and obligations of the parties to the Stipulation shall be construed and enforced in accordance with, and governed by, the laws of the State of California without giving effect to that state’s choice of law principles.

          10.18 No press announcement, press release, or other public statement concerning the Settlement may be made by any of the Settling Parties without approval from the other Settling Parties, except as required by law.

- 28 -


 

          10.19 Notices required by this Stipulation shall be submitted either by any form of overnight mail or in person to:

William B. Federman
Stuart W. Emmons
FEDERMAN & SHERWOOD
120 North Robinson, Suite 2720
Oklahoma City, OK 73102

Lead Plaintiffs’ Counsel

David Siegel
Daniel P. Lefler
Richard H. Zelichov
Pamela K. Graham
IRELL & MANELLA, LLP
1800 Avenue of the Stars, Suite 900
Los Angeles, CA 90067

Defendants’ Counsel

     IN WITNESS WHEREOF, the parties hereto have caused the Stipulation to be executed, by their duly authorized attorneys, as of March 8, 2005.

         
    FEDERMAN & SHERWOOD
 
       
  By:    
       
      William B. Federman
      wfederman@aol.com
      Stuart W. Emmons
      swe@federmanlaw.com
      Federman & Sherwood
      120 N. Robinson Avenue, Suite 2720
      Oklahoma City, Oklahoma 73102
      Telephone: (405) 235-1560
      Facsimile: (405) 239-2112
 
       
      Lead Plaintiffs’ Counsel
 
       
      and

- 29 -


 

         
      Arthur R. Angel (214611)
      The Law Offices of Arthur R. Angel
      1236 N. Fairfax Avenue
      Los Angeles, California 90046
      Telephone: (323) 656-9085
      Facsimile: (323) 656-9085
 
       
      Liaison Counsel for Lead Plaintiffs
 
       
    IRELL & MANELLA LLP
 
       
  By:    
      David Siegel (101355)
      dsiegel@irell.com
      Daniel P. Lefler (151253)
      dlefler@irell.com
      Richard H. Zelichov (193858)
      rzelichov@irell.com
      Pamela K. Graham (216309)
      pgraham@irell.com
      Irell & Manella LLP
      1800 Avenue of the Stars, Suite 900
      Los Angeles, California 90067
      Telephone: (310) 277-1010
      Facsimile: (310) 203-7199
 
       
      Attorneys for Defendants

- 30 -

 

EXHIBIT 31.1

Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by
Principal Executive Officer and Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings

    I, Jeffrey A. Quiram, certify that:
 
1.   I have reviewed this quarterly report on Form 10-Q of Superconductor Technologies Inc.;
 
2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

  a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

  a)   all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2005

             
      /s/ Jeffrey A. Quiram    
     
    Jeffrey A. Quiram
    President and Chief Executive Officer

 

 

EXHIBIT 31.2

Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by
Principal Executive Officer and Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings

    I, Martin S. McDermut, certify that:
 
1.   I have reviewed this quarterly report on Form 10-Q of Superconductor Technologies Inc.;
 
2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

  a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

  a)   all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 6, 2005

             
      /s/ Martin S. McDermut    
     
    Martin S. McDermut
    Senior Vice President, Chief Financial Officer and Secretary

 

 

EXHIBIT 32.1

Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002
By
Principal Executive Officer and Principal Financial Officer

Dated: May 6, 2005

     I, Jeffrey A. Quiram, Chief Executive Officer of Superconductor Technologies Inc, herby certify that, to my knowledge, that:

     1. the accompanying Quarterly Report on Form 10-Q of Superconductor Technologies for the three month period ended April 2, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and

     2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Superconductor Technologies Inc.

     IN WITNESS WHEREOF, the undersigned has executed this Statement as of the date first written above.

             
      /s/ Jeffrey A. Quiram    
     
    Jeffrey A. Quiram
    President and Chief Executive Officer

 

 

EXHIBIT 32.2

Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002
By
Principal Executive Officer and Principal Financial Officer

Dated: May 6, 2005

     I, Martin M. McDermut, Senior Vice President, Chief Financial Officer and Secretary of Superconductor Technologies Inc, herby certify that, to my knowledge, that:

     1. the accompanying Quarterly Report on Form 10-Q of Superconductor Technologies for the three month period ended April 2, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and

     2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Superconductor Technologies Inc.

     IN WITNESS WHEREOF, the undersigned has executed this Statement as of the date first written above.

             
      /s/ Martin S. McDermut    
     
    Martin S. McDermut
    Senior Vice President, Chief Financial Officer and Secretary